Background	Background	NN	0
Following	Following	VBG	0
a	a	DT	0
developmental	developmental	JJ	B-NP
program	program	NN	I-NP
classic	classic	JJ	I-NP
epithelial-mesenchymal	epithelial-mesenchymal	JJ	I-NP
interaction	interaction	JJ	I-NP
,	,	,	0
the	the	DT	0
mouse	mouse	NN	B-NP
neonatal	neonatal	NN	I-NP
submandibular	submandibular	NN	I-NP
salivary	salivary	JJ	I-NP
gland	gland	NN	I-NP
(	(	-LRB-	0
SMG	SMG	NNP	B-NP
)	)	-RRB-	0
is	is	VBZ	0
comprised	comprised	VBN	0
of	of	IN	0
large	large	JJ	0
and	and	CC	0
small	small	JJ	0
ducts	ducts	NNS	0
which	which	WDT	0
terminate	terminate	VBZ	0
in	in	IN	0
lumen-containing	lumen-containing	NNP	B-NP
,	,	,	0
presumptive	presumptive	JJ	B-NP
acini	acini	NN	I-NP
that	that	WDT	0
express	express	VBP	0
embryonic	embryonic	JJ	B-NP
mucin	mucin	NN	I-NP
[	[	-LRB-	0
1	1	CD	0
2	2	CD	0
3	3	CD	0
4	4	CD	0
5	5	CD	0
6	6	CD	0
7	7	CD	0
8	8	CD	0
]	]	-RRB-	0
.	.	.	0
progressive	progressive	JJ	B-NP
prenatal	prenatal	JJ	I-NP
morphogenesi	morphogenesi	NN	I-NP
begins	begins	VBZ	0
as	as	IN	0
a	a	DT	0
solid	solid	JJ	0
outgrowth	outgrowth	NN	B-NP
from	from	IN	0
the	the	DT	0
oral	oral	JJ	B-NP
epithelium	epithelium	NN	I-NP
around	around	IN	0
E11.5	E11.5	NNP	B-NP
,	,	,	0
and	and	CC	0
is	is	VBZ	0
best	best	JJS	0
conceptualized	conceptualized	NN	0
in	in	IN	0
stages	stages	NNS	0
[	[	-LRB-	0
9	9	CD	0
]	]	-RRB-	0
:	:	:	0
Initial	Initial	NNP	0
Bud	Bud	NNP	0
,	,	,	0
Pseudoglandular	Pseudoglandular	NNP	B-NP
,	,	,	0
Canalicular	Canalicular	NNP	B-NP
,	,	,	0
and	and	CC	0
Terminal	Terminal	NNP	0
Bud	Bud	NNP	0
.	.	.	0
Epithelial	Epithelial	JJ	B-NP
cell	cell	NN	I-NP
proliferation	proliferation	NN	I-NP
is	is	VBZ	0
found	found	VBN	0
in	in	IN	0
all	all	DT	0
stages	stages	NNS	0
,	,	,	0
even	even	RB	0
after	after	IN	0
well-defined	well-defined	JJ	0
lumen	lumen	JJ	B-NP
formation	formation	NN	I-NP
in	in	IN	0
the	the	DT	0
Terminal	Terminal	NNP	0
Bud	Bud	NNP	0
Stage	Stage	NNP	0
.	.	.	0
epithelial	epithelial	NN	B-NP
cell	cell	NN	I-NP
apoptosi	apoptosi	NN	I-NP
begins	begins	VBZ	0
with	with	IN	0
the	the	DT	0
onset	onset	NN	0
of	of	IN	0
lumen	lumen	JJ	B-NP
formation	formation	NN	I-NP
in	in	IN	0
the	the	DT	0
Canalicular	Canalicular	NNP	B-NP
Stage	Stage	NNP	I-NP
.	.	.	0
The	The	DT	0
proper	proper	JJ	0
balance	balance	NN	0
between	between	IN	0
SMG	SMG	NNP	B-NP
epithelial	epithelial	JJ	I-NP
cell	cell	NN	I-NP
proliferation	proliferation	NN	I-NP
,	,	,	0
quiescence	quiescence	NN	0
,	,	,	0
and	and	CC	0
apoptosi	apoptosi	NN	B-NP
is	is	VBZ	0
mediated	mediated	VBN	0
by	by	IN	0
the	the	DT	0
appearance	appearance	NN	0
of	of	IN	0
transcription	transcription	JJ	B-NP
factor	factor	NN	I-NP
,	,	,	0
growth	growth	NN	B-NP
factor	factor	NN	I-NP
,	,	,	0
cytokine	cytokine	NN	B-NP
,	,	,	0
caspa	caspa	NN	B-NP
,	,	,	0
etc.	etc.	FW	0
at	at	IN	0
specific	specific	JJ	0
times	times	NNS	0
and	and	CC	0
places	places	NNS	0
[	[	-LRB-	0
10	10	CD	0
11	11	CD	0
12	12	CD	0
13	13	CD	0
14	14	CD	0
]	]	-RRB-	0
.	.	.	0
These	These	DT	0
SMG	SMG	NNP	B-NP
cellular	cellular	JJ	I-NP
and	and	CC	0
extracellular	extracellular	JJ	B-NP
component	component	JJ	I-NP
may	may	MD	0
be	be	VB	0
visualized	visualized	VBN	0
as	as	IN	0
a	a	DT	0
Connections	Connections	NNP	B-NP
Map	Map	NNP	I-NP
which	which	WDT	0
details	details	NNS	0
the	the	DT	0
functional	functional	JJ	B-NP
relationship	relationship	NN	I-NP
within	within	IN	0
and	and	CC	0
between	between	IN	0
pathways	pathways	NNS	0
(	(	-LRB-	0
Fig.	Fig.	CD	0
1	1	CD	0
)	)	-RRB-	0
.	.	.	0
biological	biological	JJ	B-NP
signaling	signaling	JJ	I-NP
pathway	pathway	NN	I-NP
complex	complex	JJ	I-NP
network	network	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
1	1	CD	0
)	)	-RRB-	0
emerge	emerge	VB	0
from	from	IN	0
the	the	DT	0
interconnection	interconnection	NN	B-NP
of	of	IN	0
simple	simple	JJ	0
pathways	pathways	NN	0
under	under	IN	0
local	local	JJ	0
control	control	NN	0
[	[	-LRB-	0
15	15	CD	0
16	16	CD	0
17	17	CD	0
]	]	-RRB-	0
.	.	.	0
As	As	IN	0
such	such	JJ	0
,	,	,	0
these	these	DT	0
cellular	cellular	JJ	B-NP
pathway	pathway	NN	I-NP
are	are	VBP	0
more	more	RBR	0
analogous	analogous	JJ	0
to	to	TO	0
the	the	DT	0
mostly	mostly	RB	0
redundant	redundant	JJ	0
,	,	,	0
overlapping	overlapping	VBG	0
neural	neural	JJ	B-NP
network	network	NN	I-NP
of	of	IN	0
the	the	DT	0
brain	brain	NN	0
than	than	IN	0
to	to	TO	0
traffic	traffic	NN	B-NP
grid	grid	NN	I-NP
of	of	IN	0
intersecting	intersecting	JJ	0
streets	streets	NNS	0
and	and	CC	0
interacting	interacting	JJ	0
vehicles	vehicles	NNS	0
.	.	.	0
There	There	EX	0
are	are	VBP	0
two	two	CD	0
general	general	NN	0
,	,	,	0
not	not	RB	0
mutually	mutually	RB	0
exclusive	exclusive	JJ	B-NP
,	,	,	0
classes	classes	NNS	0
of	of	IN	0
interconnection	interconnection	NN	B-NP
:	:	:	0
(	(	-LRB-	0
1	1	LS	0
)	)	-RRB-	0
junctions	junctions	NN	0
which	which	WDT	0
serve	serve	VBP	0
as	as	RB	0
signal	signal	VB	0
integrator	integrator	NN	B-NP
and	and	CC	0
(	(	-LRB-	0
2	2	LS	0
)	)	-RRB-	0
nodes	nodes	NN	0
which	which	WDT	0
split	split	VBD	0
the	the	DT	0
signal	signal	NN	0
and	and	CC	0
route	route	NN	0
them	them	PRP	0
to	to	TO	0
multiple	multiple	JJ	0
output	output	NN	B-NP
[	[	-LRB-	0
18	18	CD	0
]	]	-RRB-	0
.	.	.	0
Understanding	Understanding	VBG	0
the	the	DT	0
nonlinear	nonlinear	JJ	B-NP
dynamic	dynamic	JJ	I-NP
of	of	IN	0
these	these	DT	0
interconnection	interconnection	NN	B-NP
is	is	VBZ	0
intrinsic	intrinsic	VBN	0
to	to	TO	0
understanding	understanding	VB	0
the	the	DT	0
regulation	regulation	NN	0
of	of	IN	0
smg	smg	NN	B-NP
morphogenesi	morphogenesi	NN	I-NP
.	.	.	0
This	This	DT	0
requires	requires	VBZ	0
the	the	DT	0
integration	integration	NN	0
of	of	IN	0
transcriptomic	transcriptomic	NN	B-NP
,	,	,	0
proteomic	proteomic	NN	B-NP
,	,	,	0
phenomic	phenomic	NN	B-NP
,	,	,	0
and	and	CC	0
bioinformatic	bioinformatic	JJ	B-NP
approach	approach	NN	I-NP
,	,	,	0
not	not	RB	0
least	least	JJS	0
because	because	IN	0
development	development	NN	0
,	,	,	0
in	in	IN	0
its	its	PRP$	0
most	most	RBS	0
basic	basic	JJ	0
sense	sense	NN	0
,	,	,	0
is	is	VBZ	0
genes	genes	NNS	0
plus	plus	CC	0
context	context	NN	0
[	[	-LRB-	0
19	19	CD	0
20	20	CD	0
21	21	CD	0
22	22	CD	0
]	]	-RRB-	0
.	.	.	0
With	With	IN	0
the	the	DT	0
present	present	JJ	0
experiments	experiments	NNS	0
,	,	,	0
we	we	PRP	0
sought	sought	VBD	0
a	a	DT	0
glimpse	glimpse	NN	0
of	of	IN	0
the	the	DT	0
extraordinarily	extraordinarily	JJ	0
complex	complex	JJ	0
behaviors	behaviors	NN	0
of	of	IN	0
a	a	DT	0
focused	focused	VBN	0
signaling	signaling	VBG	B-NP
network	network	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
1	1	CD	0
)	)	-RRB-	0
.	.	.	0
To	To	TO	0
this	this	DT	0
end	end	NN	0
,	,	,	0
we	we	PRP	0
studied	studied	VBD	0
the	the	DT	0
molecular	molecular	JJ	B-NP
pattern	pattern	NN	I-NP
and	and	CC	0
nodal	nodal	JJ	B-NP
phenotypic	phenotypic	JJ	I-NP
outcome	outcome	NN	I-NP
"short	"short	CD	0
circuit	circuit	NN	0
"	"	''	0
,	,	,	0
i.e.	i.e.	FW	0
,	,	,	0
the	the	DT	0
inhibition	inhibition	NN	0
of	of	IN	0
NF-κB	NF-κB	JJ	B-NP
activation	activation	NN	I-NP
and	and	CC	0
translocation	translocation	JJ	0
to	to	TO	0
the	the	DT	0
nucleus	nucleus	NN	B-NP
to	to	TO	0
bind	bind	VB	0
to	to	TO	0
nf-κb	nf-κb	NN	B-NP
response	response	NN	I-NP
gene	gene	NN	I-NP
.	.	.	0
In	In	IN	0
most	most	JJS	0
cell	cell	NN	0
types	types	NNS	0
,	,	,	0
the	the	DT	0
NF-κB	NF-κB	JJ	B-NP
p50	p50	CD	I-NP
/	/	CD	0
p65	p65	CD	B-NP
heterodimer	heterodimer	NN	I-NP
is	is	VBZ	0
maintained	maintained	VBN	0
as	as	IN	0
an	an	DT	0
inactive	inactive	JJ	B-NP
form	form	NN	I-NP
in	in	IN	0
the	the	DT	0
cytoplasm	cytoplasm	NN	B-NP
bound	bound	VBN	0
to	to	TO	0
the	the	DT	0
inhibitory	inhibitory	JJ	B-NP
protein	protein	NN	I-NP
IκB	IκB	NN	I-NP
.	.	.	0
Exposure	Exposure	NN	0
of	of	IN	0
cells	cells	NNS	0
to	to	TO	0
stimuli	stimuli	VB	0
of	of	IN	0
NF-κB	NF-κB	NNP	B-NP
induces	induces	VBZ	0
the	the	DT	0
rapid	rapid	JJ	B-NP
phosphorylation	phosphorylation	NN	I-NP
and	and	CC	0
subsequent	subsequent	JJ	0
degradation	degradation	NN	0
of	of	IN	0
iκb	iκb	NN	B-NP
protein	protein	NN	I-NP
.	.	.	0
released	released	VBN	B-NP
nf-κb	nf-κb	NN	I-NP
dimer	dimer	NN	I-NP
then	then	RB	0
translocate	translocate	VBN	0
to	to	TO	0
the	the	DT	0
nucleus	nucleus	NN	B-NP
,	,	,	0
bind	bind	NN	0
to	to	TO	0
its	its	PRP$	0
cognate	cognate	JJ	0
dna	dna	NN	B-NP
element	element	NN	I-NP
,	,	,	0
and	and	CC	0
induce	induce	VB	0
the	the	DT	0
expression	expression	NN	0
of	of	IN	0
target	target	NN	B-NP
gene	gene	NN	I-NP
[	[	-LRB-	0
23	23	CD	0
24	24	CD	0
25	25	CD	0
]	]	-RRB-	0
.	.	.	0
Activated	Activated	NNP	0
,	,	,	0
nuclear	nuclear	JJ	0
translocated	translocated	NN	0
,	,	,	0
NF-κB	NF-κB	JJ	B-NP
transcription	transcription	JJ	I-NP
factor	factor	NN	I-NP
has	has	VBZ	0
been	been	VBN	0
documented	documented	VBN	0
in	in	IN	0
the	the	DT	0
mouse	mouse	NN	B-NP
embryo	embryo	NN	I-NP
from	from	IN	0
the	the	DT	0
1-cell	1-cell	JJ	0
stage	stage	NN	0
onward	onward	NNS	0
[	[	-LRB-	0
26	26	CD	0
27	27	CD	0
]	]	-RRB-	0
.	.	.	0
Activated	Activated	JJ	B-NP
NF-κB	NF-κB	JJ	I-NP
translocation	translocation	NN	I-NP
into	into	IN	0
the	the	DT	0
nucleus	nucleus	NN	B-NP
,	,	,	0
directly	directly	RB	0
or	or	CC	0
indirectly	indirectly	RB	0
,	,	,	0
effects	effects	NNS	0
the	the	DT	0
transcriptional	transcriptional	JJ	B-NP
control	control	NN	I-NP
of	of	IN	0
over	over	IN	0
150	150	CD	0
target	target	NN	B-NP
gene	gene	NN	I-NP
[	[	-LRB-	0
28	28	CD	0
]	]	-RRB-	0
.	.	.	0
NF-κB	NF-κB	JJ	B-NP
enhances	enhances	JJ	0
cell	cell	NN	0
proliferation	proliferation	NN	0
by	by	IN	0
stimulating	stimulating	VBG	0
the	the	DT	0
expression	expression	NN	0
of	of	IN	0
cytokines	cytokines	JJ	0
such	such	JJ	0
as	as	IN	0
tumor	tumor	NN	B-NP
necrosi	necrosi	NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
factor	factor	NN	I-NP
,	,	,	0
IL-1	IL-1	NNP	B-NP
,	,	,	0
interleukin	interleukin	NN	B-NP
2	2	NN	I-NP
,	,	,	0
IL-6	IL-6	NNP	B-NP
,	,	,	0
and	and	CC	0
IL-8	IL-8	NNP	B-NP
,	,	,	0
among	among	IN	0
others	others	NNS	0
[	[	-LRB-	0
28	28	CD	0
29	29	CD	0
]	]	-RRB-	0
;	;	:	0
NF-κB	NF-κB	JJ	B-NP
inhibits	inhibits	JJ	0
apoptosi	apoptosi	NN	B-NP
by	by	IN	0
inducing	inducing	VBG	B-NP
TRAF	TRAF	NNP	I-NP
and	and	CC	0
clAP	clAP	JJ	0
expression	expression	NN	0
which	which	WDT	0
suppresses	suppresses	VBZ	0
Caspase	Caspase	NNP	B-NP
8	8	CD	0
activation	activation	NN	B-NP
[	[	-LRB-	0
30	30	CD	0
]	]	-RRB-	0
,	,	,	0
and	and	CC	0
by	by	IN	0
inhibition	inhibition	NN	0
of	of	IN	0
p53	p53	NN	B-NP
transactivation	transactivation	NN	I-NP
[	[	-LRB-	0
31	31	CD	0
32	32	CD	0
]	]	-RRB-	0
.	.	.	0
We	We	PRP	0
interrupted	interrupted	VBD	0
the	the	DT	0
NF-κB	NF-κB	JJ	B-NP
signal	signal	NN	I-NP
in	in	IN	0
embryonic	embryonic	JJ	B-NP
SMG	SMG	NN	I-NP
explants	explants	VBP	0
using	using	VBG	0
the	the	DT	0
cell-permeable	cell-permeable	JJ	0
peptide	peptide	JJ	B-NP
SN50	SN50	NN	I-NP
,	,	,	0
a	a	DT	0
potent	potent	JJ	0
inhibitor	inhibitor	NN	0
of	of	IN	0
NF-κB	NF-κB	JJ	B-NP
nuclear	nuclear	JJ	0
translocation	translocation	NN	B-NP
[	[	-LRB-	0
25	25	CD	0
26	26	CD	0
]	]	-RRB-	0
,	,	,	0
[	[	-LRB-	0
33	33	CD	0
34	34	CD	0
35	35	CD	0
]	]	-RRB-	0
.	.	.	0
nf-κb	nf-κb	NN	B-NP
sn50-mediated	sn50-mediated	NN	I-NP
inhibition	inhibition	NN	I-NP
nuclear	nuclear	JJ	0
translocation	translocation	NN	B-NP
in	in	IN	0
smg	smg	NN	B-NP
explants	explants	NN	I-NP
result	result	NN	I-NP
in	in	IN	0
extensive	extensive	JJ	B-NP
apoptosi	apoptosi	NN	I-NP
and	and	CC	0
a	a	DT	0
very	very	RB	0
substantial	substantial	JJ	0
decline	decline	NN	0
in	in	IN	0
cell	cell	NN	0
proliferation	proliferation	NN	0
.	.	.	0
functional	functional	JJ	B-NP
genomic	genomic	JJ	I-NP
analysis	analysis	NN	I-NP
demonstrate	demonstrate	VBP	0
that	that	DT	0
inhibition	inhibition	NN	0
of	of	IN	0
NF-κB	NF-κB	JJ	B-NP
signaling	signaling	NN	I-NP
is	is	VBZ	0
associated	associated	VBN	0
with	with	IN	0
the	the	DT	0
altered	altered	JJ	0
expression	expression	NN	0
of	of	IN	0
genetic	genetic	JJ	B-NP
network	network	NN	I-NP
numerous	numerous	JJ	I-NP
component	component	JJ	I-NP
of	of	IN	0
related	related	JJ	0
signaling	signaling	JJ	0
pathways	pathways	NN	0
.	.	.	0
This	This	DT	0
modified	modified	JJ	0
expression	expression	NN	0
of	of	IN	0
genes	genes	NNS	0
and	and	CC	0
proteins	proteins	NNS	0
associated	associated	VBN	0
with	with	IN	0
the	the	DT	0
inhibition	inhibition	NN	0
of	of	IN	0
the	the	DT	0
cell	cell	NN	B-NP
cycle	cycle	NN	I-NP
and	and	CC	0
the	the	DT	0
apoptosi	apoptosi	NN	B-NP
induction	induction	NN	I-NP
,	,	,	0
as	as	RB	0
well	well	RB	0
as	as	IN	0
the	the	DT	0
increased	increased	JJ	0
proapoptotic	proapoptotic	NN	B-NP
activation	activation	NN	I-NP
and	and	CC	0
compensatory	compensatory	JJ	B-NP
antiapoptotic	antiapoptotic	JJ	I-NP
pathway	pathway	NN	I-NP
,	,	,	0
provides	provides	VBZ	0
a	a	DT	0
"snapshot	"snapshot	NN	0
"	"	''	0
of	of	IN	0
the	the	DT	0
broad	broad	JJ	0
primary	primary	JJ	0
and	and	CC	0
nf-κb	nf-κb	NN	B-NP
signaling	signaling	NN	I-NP
secondary	secondary	JJ	I-NP
effect	effect	NN	I-NP
during	during	IN	0
SMG	SMG	NNP	B-NP
development	development	NN	I-NP
.	.	.	0
Results	Results	NNS	0
and	and	CC	0
discussion	discussion	NN	0
NF-κB	NF-κB	JJ	B-NP
inhibition	inhibition	NN	I-NP
and	and	CC	0
submandibular	submandibular	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
salivary	salivary	JJ	I-NP
gland	gland	NN	I-NP
phenotype	phenotype	VBD	0
E15	E15	NNP	B-NP
SMG	SMG	NNP	I-NP
primordia	primordia	NN	I-NP
were	were	VBD	0
cultured	cultured	VBN	0
for	for	IN	0
2	2	CD	0
days	days	NNS	0
in	in	IN	0
the	the	DT	0
presence	presence	NN	0
or	or	CC	0
absence	absence	NN	B-NP
of	of	IN	0
the	the	DT	0
cell-permeable	cell-permeable	JJ	0
peptide	peptide	JJ	B-NP
SN50	SN50	NN	I-NP
,	,	,	0
a	a	DT	0
potent	potent	JJ	0
inhibitor	inhibitor	NN	0
of	of	IN	0
NF-κB	NF-κB	JJ	B-NP
nuclear	nuclear	JJ	0
translocation	translocation	NN	B-NP
[	[	-LRB-	0
33	33	CD	0
34	34	CD	0
35	35	CD	0
]	]	-RRB-	0
.	.	.	0
SN50	SN50	NNP	B-NP
is	is	VBZ	0
composed	composed	VBN	0
of	of	IN	0
a	a	DT	0
nuclear	nuclear	JJ	B-NP
localization	localization	JJ	I-NP
sequence	sequence	NN	I-NP
(	(	-LRB-	0
nuclear	nuclear	JJ	B-NP
localization	localization	NN	I-NP
signal	signal	NN	I-NP
)	)	-RRB-	0
for	for	IN	0
NF-κB	NF-κB	JJ	B-NP
p50	p50	NN	I-NP
linked	linked	VBN	0
to	to	TO	0
a	a	DT	0
cell-permeable	cell-permeable	JJ	0
carrier	carrier	NN	B-NP
[	[	-LRB-	0
33	33	CD	0
34	34	CD	0
35	35	CD	0
]	]	-RRB-	0
.	.	.	0
SN50	SN50	NNP	B-NP
blocks	blocks	VBZ	0
the	the	DT	0
nuclear	nuclear	JJ	B-NP
localization	localization	NN	I-NP
signal	signal	NN	I-NP
intracellular	intracellular	JJ	I-NP
recognition	recognition	NN	I-NP
mechanism	mechanism	NN	I-NP
on	on	IN	0
NF-κB	NF-κB	NNP	B-NP
,	,	,	0
thus	thus	RB	0
inhibiting	inhibiting	JJ	0
NF-κB	NF-κB	NN	0
's	's	POS	0
translocation	translocation	NN	B-NP
through	through	IN	0
the	the	DT	0
nuclear	nuclear	JJ	0
pore	pore	NN	0
.	.	.	0
After	After	IN	0
2	2	CD	0
days	days	NNS	0
in	in	IN	0
culture	culture	NN	0
,	,	,	0
sn50-treated	sn50-treated	NN	B-NP
explant	explant	NN	I-NP
exhibit	exhibit	VBP	0
a	a	DT	0
substantial	substantial	JJ	0
decrease	decrease	NN	0
in	in	IN	0
gland	gland	JJ	0
size	size	NN	0
and	and	CC	0
branching	branching	NNS	0
morphogenesis	morphogenesis	VBP	0
compared	compared	VBN	0
to	to	TO	0
controls	controls	NNS	0
(	(	-LRB-	0
compare	compare	FW	0
Fig.	Fig.	FW	0
3Ato	3Ato	FW	0
3B	3B	FW	0
)	)	-RRB-	0
.	.	.	0
These	These	DT	0
2-day	2-day	CD	0
sn50-treated	sn50-treated	NN	B-NP
explant	explant	NN	I-NP
demonstrate	demonstrate	VBP	0
a	a	DT	0
highly	highly	RB	0
significant	significant	JJ	0
81	81	CD	0
%	%	NN	0
decline	decline	NN	0
(	(	-LRB-	0
t	t	CD	0
4	4	CD	0
=	=	SYM	0
26.25	26.25	CD	0
;	;	:	0
p	p	CD	0
<	<	SYM	0
0.001	0.001	CD	0
)	)	-RRB-	0
in	in	IN	0
cell	cell	NN	0
proliferation	proliferation	NN	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
3A	3A	NNP	0
,	,	,	0
B	B	NNP	0
;	;	:	0
Fig.	Fig.	CD	0
4A	4A	CD	0
)	)	-RRB-	0
and	and	CC	0
a	a	DT	0
significant	significant	JJ	0
10-fold	10-fold	JJ	0
increase	increase	NN	0
(	(	-LRB-	0
t	t	CD	0
4	4	CD	0
=	=	SYM	0
7.98	7.98	CD	0
;	;	:	0
p	p	CD	0
<	<	SYM	0
0.001	0.001	CD	0
)	)	-RRB-	0
in	in	IN	0
apoptosi	apoptosi	NN	B-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
3C	3C	NNP	0
,	,	,	0
D	D	NNP	0
;	;	:	0
Fig.	Fig.	CD	0
4B	4B	CD	0
)	)	-RRB-	0
.	.	.	0
This	This	DT	0
substantial	substantial	JJ	0
increase	increase	NN	0
in	in	IN	0
apoptosi	apoptosi	NN	B-NP
is	is	VBZ	0
associated	associated	VBN	0
with	with	IN	0
a	a	DT	0
highly	highly	RB	0
significant	significant	JJ	0
>	>	CD	0
4-fold	4-fold	CD	0
increase	increase	NN	0
(	(	-LRB-	0
t	t	CD	0
4	4	CD	0
=	=	SYM	0
22.66	22.66	CD	0
;	;	:	0
p	p	CD	0
<	<	SYM	0
0.001	0.001	CD	0
)	)	-RRB-	0
in	in	IN	0
activated	activated	NNS	0
(	(	-LRB-	0
phosphorylated	phosphorylated	LS	0
)	)	-RRB-	0
p53	p53	NN	B-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
5	5	CD	0
)	)	-RRB-	0
.	.	.	0
This	This	DT	0
result	result	NN	0
is	is	VBZ	0
not	not	RB	0
surprising	surprising	JJ	0
,	,	,	0
given	given	VBN	0
that	that	IN	0
NF-κB	NF-κB	JJ	B-NP
inactivates	inactivates	JJ	0
p53	p53	NN	B-NP
[	[	-LRB-	0
32	32	CD	0
]	]	-RRB-	0
.	.	.	0
To	To	TO	0
demonstrate	demonstrate	VB	0
that	that	IN	0
this	this	DT	0
SN50	SN50	JJ	B-NP
phenotype	phenotype	NN	I-NP
is	is	VBZ	0
consequent	consequent	VBN	0
to	to	TO	0
nf-κb	nf-κb	NN	B-NP
sn50-mediated	sn50-mediated	NN	I-NP
inhibition	inhibition	NN	I-NP
nuclear	nuclear	JJ	0
translocation	translocation	NN	B-NP
and	and	CC	0
not	not	RB	0
the	the	DT	0
exogenous	exogenous	JJ	B-NP
peptide	peptide	NN	I-NP
nonspecific	nonspecific	JJ	I-NP
effect	effect	NN	I-NP
,	,	,	0
we	we	PRP	0
compared	compared	VBD	0
E15	E15	CD	B-NP
+	+	CD	0
2	2	CD	0
smg	smg	NN	B-NP
phenotype	phenotype	NN	I-NP
in	in	IN	0
explants	explants	JJ	B-NP
cultured	cultured	NN	I-NP
in	in	IN	0
control	control	NN	B-NP
medium	medium	JJ	I-NP
,	,	,	0
100	100	CD	0
μg	μg	NN	B-NP
/	/	NN	I-NP
ml	ml	NN	I-NP
SN50	SN50	NN	I-NP
peptide	peptide	NN	I-NP
,	,	,	0
or	or	CC	0
100	100	CD	0
μg	μg	NN	B-NP
/	/	NN	I-NP
ml	ml	NN	I-NP
mutant	mutant	NN	I-NP
SN50	SN50	NN	I-NP
(	(	-LRB-	0
mSN50	mSN50	NNP	B-NP
)	)	-RRB-	0
peptide	peptide	NN	B-NP
.	.	.	0
As	As	RB	0
expected	expected	VBN	0
,	,	,	0
we	we	PRP	0
found	found	VBD	0
a	a	DT	0
marked	marked	JJ	0
difference	difference	NN	0
between	between	IN	0
control	control	NN	0
and	and	CC	0
sn50-treated	sn50-treated	NN	B-NP
smg	smg	NN	I-NP
but	but	CC	0
none	none	NN	0
between	between	IN	0
control	control	NN	0
and	and	CC	0
mutant	mutant	JJ	B-NP
peptide-treated	peptide-treated	JJ	I-NP
explant	explant	NN	I-NP
(	(	-LRB-	0
data	data	NNS	0
not	not	RB	0
shown	shown	VBN	0
)	)	-RRB-	0
.	.	.	0
In	In	IN	0
addition	addition	NN	B-NP
,	,	,	0
since	since	IN	0
tumor	tumor	NN	B-NP
necrosi	necrosi	NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
factor	factor	NN	I-NP
/	/	NNP	0
TNFR1	TNFR1	NNP	B-NP
signaling	signaling	NN	I-NP
has	has	VBZ	0
been	been	VBN	0
shown	shown	VBN	0
to	to	TO	0
induce	induce	VB	0
embryonic	embryonic	JJ	B-NP
SMG	SMG	NNP	I-NP
cell	cell	NN	I-NP
proliferation	proliferation	NN	I-NP
and	and	CC	0
inhibit	inhibit	VB	0
apoptosis	apoptosis	VBN	0
in	in	IN	0
vitro	vitro	NN	B-NP
[	[	-LRB-	0
13	13	CD	0
]	]	-RRB-	0
and	and	CC	0
tumor	tumor	NN	B-NP
necrosi	necrosi	NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
factor	factor	NN	I-NP
/	/	NNP	0
TNFR1	TNFR1	NNP	B-NP
signal	signal	NN	I-NP
transduction	transduction	VBZ	0
primarily	primarily	RB	0
signals	signals	VBZ	0
by	by	IN	0
nf-κb	nf-κb	NN	B-NP
induction	induction	NN	I-NP
nuclear	nuclear	JJ	0
translocation	translocation	NN	B-NP
[	[	-LRB-	0
36	36	CD	0
]	]	-RRB-	0
,	,	,	0
we	we	PRP	0
postulated	postulated	VBD	0
that	that	IN	0
TNF	TNF	NNP	B-NP
supplementation	supplementation	NN	I-NP
should	should	MD	0
have	have	VB	0
no	no	DT	0
inductive	inductive	JJ	B-NP
effect	effect	NN	I-NP
on	on	IN	0
sn50-treated	sn50-treated	NN	B-NP
smg	smg	NN	I-NP
.	.	.	0
Thus	Thus	RB	0
,	,	,	0
we	we	PRP	0
cultured	cultured	VBD	0
E15	E15	CD	B-NP
control	control	NN	I-NP
,	,	,	0
SN50-treated	SN50-treated	NNP	B-NP
,	,	,	0
and	and	CC	0
msn50-treated	msn50-treated	NN	B-NP
explant	explant	NN	I-NP
in	in	IN	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
tumor	tumor	NN	B-NP
necrosi	necrosi	NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
factor	factor	NN	I-NP
(	(	-LRB-	0
rTNF	rTNF	NNP	B-NP
,	,	,	0
10	10	CD	0
U	U	NNP	B-NP
/	/	CD	I-NP
ml	ml	CD	I-NP
)	)	-RRB-	0
supplementation	supplementation	NN	B-NP
for	for	IN	0
4	4	CD	0
or	or	CC	0
more	more	JJR	0
days	days	NNS	0
.	.	.	0
In	In	IN	0
this	this	DT	0
set	set	NN	0
of	of	IN	0
experiments	experiments	NNS	0
,	,	,	0
we	we	PRP	0
extended	extended	VBD	0
the	the	DT	0
culture	culture	NN	0
period	period	NN	0
to	to	TO	0
provide	provide	VB	0
sufficient	sufficient	JJ	0
time	time	NN	0
to	to	TO	0
allow	allow	VB	0
for	for	IN	0
possible	possible	JJ	0
TNF-mediated	TNF-mediated	JJ	B-NP
recovery	recovery	NN	I-NP
.	.	.	0
induced	induced	VBN	B-NP
nf-κb	nf-κb	NN	I-NP
tnf	tnf	NN	I-NP
supplementation	supplementation	NN	I-NP
(	(	-LRB-	0
p50	p50	NNP	B-NP
and	and	CC	0
p65	p65	CD	B-NP
)	)	-RRB-	0
translocation	translocation	NN	B-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
6A	6A	NNP	0
)	)	-RRB-	0
,	,	,	0
a	a	DT	0
marked	marked	JJ	0
increase	increase	NN	0
in	in	IN	0
explant	explant	JJ	B-NP
size	size	NN	I-NP
,	,	,	0
and	and	CC	0
a	a	DT	0
notable	notable	JJ	0
increase	increase	NN	0
in	in	IN	0
cell	cell	NN	0
proliferation	proliferation	NN	0
(	(	-LRB-	0
not	not	RB	0
shown	shown	VBN	0
)	)	-RRB-	0
;	;	:	0
similar	similar	JJ	0
results	results	NNS	0
were	were	VBD	0
seen	seen	VBN	0
in	in	IN	0
tumor	tumor	NN	B-NP
necrosi	necrosi	NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
factor	factor	NN	I-NP
msn50-treated	msn50-treated	NN	B-NP
explant	explant	NN	I-NP
(	(	-LRB-	0
not	not	RB	0
shown	shown	VBN	0
)	)	-RRB-	0
.	.	.	0
By	By	IN	0
contrast	contrast	NN	0
,	,	,	0
NF-κB	NF-κB	JJ	B-NP
redistribution	redistribution	NN	I-NP
was	was	VBD	0
not	not	RB	0
found	found	VBN	0
in	in	IN	0
explants	explants	JJ	B-NP
cultured	cultured	NN	I-NP
in	in	IN	0
tumor	tumor	NN	B-NP
necrosi	necrosi	NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
factor	factor	NN	I-NP
+	+	NNP	0
SN50	SN50	NNP	B-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
6B	6B	NNP	0
)	)	-RRB-	0
;	;	:	0
rather	rather	RB	0
,	,	,	0
NF-κB	NF-κB	NNP	B-NP
was	was	VBD	0
absent	absent	VBN	0
from	from	IN	0
epithelial	epithelial	JJ	B-NP
cell	cell	NN	I-NP
nucleus	nucleus	NN	I-NP
and	and	CC	0
exhibited	exhibited	VBN	0
a	a	DT	0
very	very	RB	0
weak	weak	JJ	0
,	,	,	0
diffuse	diffuse	JJ	0
cytoplasmic	cytoplasmic	JJ	B-NP
distribution	distribution	NN	I-NP
.	.	.	0
Moreover	Moreover	RB	0
,	,	,	0
TNF	TNF	NNP	B-NP
supplementation	supplementation	NN	I-NP
was	was	VBD	0
unable	unable	JJ	0
to	to	TO	0
rescue	rescue	VB	0
the	the	DT	0
abnormal	abnormal	JJ	0
SN50	SN50	CD	B-NP
phenotypa	phenotypa	NN	I-NP
.	.	.	0
Finally	Finally	RB	0
,	,	,	0
the	the	DT	0
identical	identical	JJ	0
response	response	NN	0
of	of	IN	0
control	control	NN	0
and	and	CC	0
mSN50-treated	mSN50-treated	NNP	B-NP
SMG	SMG	NNP	I-NP
explants	explants	VBD	0
to	to	TO	0
TNF	TNF	NNP	B-NP
supplementation	supplementation	NN	I-NP
provides	provides	VBZ	0
further	further	JJ	0
evidence	evidence	NN	0
that	that	IN	0
this	this	DT	0
mutant	mutant	JJ	B-NP
peptide	peptide	NN	I-NP
had	had	VBD	0
no	no	DT	0
effect	effect	NN	0
on	on	IN	0
NF-κB	NF-κB	JJ	B-NP
activation	activation	NN	I-NP
.	.	.	0
Transcriptomic	Transcriptomic	JJ	B-NP
analysis	analysis	NN	I-NP
To	To	TO	0
investigate	investigate	VB	0
transcriptional	transcriptional	JJ	B-NP
response	response	NN	I-NP
to	to	TO	0
NF-κB	NF-κB	JJ	B-NP
inhibition	inhibition	NN	I-NP
,	,	,	0
we	we	PRP	0
analyzed	analyzed	VBD	B-NP
control	control	NN	I-NP
and	and	CC	0
SN50-treated	SN50-treated	CD	B-NP
E15	E15	CD	I-NP
+	+	CD	0
2	2	CD	0
submandibular	submandibular	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
salivary	salivary	JJ	I-NP
gland	gland	NN	I-NP
explants	explants	VBP	0
using	using	VBG	0
cdna	cdna	NN	B-NP
array	array	NN	I-NP
.	.	.	0
Of	Of	IN	0
the	the	DT	0
1176	1176	CD	0
transcripts	transcripts	NNS	0
assayed	assayed	VBN	0
on	on	IN	0
these	these	DT	0
arrays	arrays	NN	0
(	(	-LRB-	0
including	including	VBG	B-NP
transcription	transcription	JJ	I-NP
factor	factor	NN	I-NP
,	,	,	0
cell	cell	NN	0
cycle	cycle	NN	0
regulators	regulators	NNS	0
,	,	,	0
growth	growth	NN	B-NP
factor	factor	NN	I-NP
,	,	,	0
etc.	etc.	FW	0
)	)	-RRB-	0
,	,	,	0
691	691	CD	0
(	(	-LRB-	0
~60	~60	NNP	0
%	%	NN	0
)	)	-RRB-	0
demonstrated	demonstrated	VBD	0
a	a	DT	0
1.5-fold	1.5-fold	NNP	0
or	or	CC	0
greater	greater	JJR	0
increase	increase	NN	0
or	or	CC	0
decrease	decrease	NN	0
in	in	IN	0
expression	expression	NN	0
with	with	IN	0
SN50-induced	SN50-induced	CD	B-NP
NF-κB	NF-κB	JJ	I-NP
inhibition	inhibition	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
7	7	CD	0
)	)	-RRB-	0
.	.	.	0
Of	Of	IN	0
these	these	DT	0
,	,	,	0
we	we	PRP	0
focused	focused	VBD	0
our	our	PRP$	0
attention	attention	NN	0
on	on	IN	0
those	those	DT	0
signal	signal	NN	B-NP
transduction	transduction	NN	I-NP
,	,	,	0
cell	cell	NN	B-NP
cycle	cycle	NN	I-NP
,	,	,	0
and	and	CC	0
apoptosis	apoptosis	JJ	B-NP
transcript	transcript	NN	I-NP
related	related	VBN	0
to	to	TO	0
the	the	DT	0
Connections	Connections	NNP	B-NP
Map	Map	NNP	I-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
1	1	CD	0
)	)	-RRB-	0
.	.	.	0
With	With	IN	0
inhibition	inhibition	NN	0
of	of	IN	0
NF-κB	NF-κB	JJ	B-NP
translocation	translocation	NN	I-NP
into	into	IN	0
the	the	DT	0
nucleus	nucleus	NN	B-NP
,	,	,	0
53	53	CD	0
Connections	Connections	NNP	0
altered	altered	VBN	B-NP
expression	expression	NN	I-NP
map	map	NN	I-NP
transcripts	transcripts	NNS	I-NP
exhibit	exhibit	NN	I-NP
(	(	-LRB-	0
Table	Table	NNP	0
1	1	CD	0
)	)	-RRB-	0
.	.	.	0
We	We	PRP	0
used	used	VBD	0
Probabilistic	Probabilistic	NNP	B-NP
Neural	Neural	NNP	I-NP
Network	Network	NNP	I-NP
(	(	-LRB-	0
PNN	PNN	NNP	B-NP
)	)	-RRB-	0
analyses	analyses	NNS	0
to	to	TO	0
determine	determine	VB	0
which	which	WDT	0
transcript	transcript	VBP	B-NP
change	change	NN	I-NP
best	best	RBS	0
discriminate	discriminate	JJ	0
control	control	NN	0
from	from	IN	0
sn50-treated	sn50-treated	NN	B-NP
explant	explant	NN	I-NP
.	.	.	0
These	These	DT	0
analyses	analyses	NNS	0
identified	identified	VBD	0
those	those	DT	0
transcripts	transcripts	NNS	0
with	with	IN	0
significant	significant	JJ	0
changes	changes	NNS	0
which	which	WDT	0
are	are	VBP	0
relatively	relatively	RB	0
more	more	RBR	0
important	important	JJ	0
in	in	IN	0
defining	defining	VBG	0
the	the	DT	0
SMG	SMG	NNP	B-NP
phenotype	phenotype	NN	I-NP
,	,	,	0
regardless	regardless	RB	0
of	of	IN	0
the	the	DT	0
direction	direction	NN	0
(	(	-LRB-	0
up	up	RB	0
or	or	CC	0
down	down	RB	0
)	)	-RRB-	0
of	of	IN	0
change	change	NN	0
.	.	.	0
Among	Among	IN	0
the	the	DT	0
cell	cell	NN	0
cycle	cycle	NN	0
transcripts	transcripts	NNS	0
with	with	IN	0
altered	altered	JJ	0
expression	expression	NN	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
8A	8A	NNP	0
)	)	-RRB-	0
,	,	,	0
pnn	pnn	NN	B-NP
analysis	analysis	NN	I-NP
show	show	NN	I-NP
that	that	IN	0
the	the	DT	0
increased	increased	JJ	0
expression	expression	NN	0
of	of	IN	0
cyclin	cyclin	CD	B-NP
D2	D2	CD	I-NP
,	,	,	0
p57	p57	NNP	B-NP
,	,	,	0
and	and	CC	0
Cdc25a	Cdc25a	NNP	0
,	,	,	0
as	as	RB	0
well	well	RB	0
as	as	IN	0
decreased	decreased	JJ	0
expression	expression	NN	0
of	of	IN	0
PCNA	PCNA	NNP	B-NP
,	,	,	0
best	best	RBS	0
discriminate	discriminate	JJ	0
control	control	NN	0
from	from	IN	0
sn50-treated	sn50-treated	NN	B-NP
explant	explant	NN	I-NP
.	.	.	0
Cyclin	Cyclin	NNP	B-NP
D2	D2	NNP	I-NP
,	,	,	0
Cdc25a	Cdc25a	NNP	0
,	,	,	0
and	and	CC	0
PCNA	PCNA	NNP	B-NP
promote	promote	VB	0
cell	cell	NN	0
division	division	NN	0
;	;	:	0
p57	p57	CD	B-NP
inhibits	inhibits	JJ	0
cell	cell	NN	0
division	division	NN	0
(	(	-LRB-	0
Fig.	Fig.	CD	0
1	1	CD	0
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
significant	significant	JJ	0
decline	decline	NN	0
in	in	IN	0
PCNA	PCNA	NNP	B-NP
transcript	transcript	NN	I-NP
(	(	-LRB-	0
Table	Table	NNP	0
1	1	CD	0
)	)	-RRB-	0
is	is	VBZ	0
consistent	consistent	JJ	0
with	with	IN	0
the	the	DT	0
highly	highly	RB	0
significant	significant	JJ	0
(	(	-LRB-	0
p	p	FW	0
<	<	SYM	0
0.001	0.001	FW	0
)	)	-RRB-	0
decline	decline	NN	0
in	in	IN	0
PCNA-defined	PCNA-defined	JJ	B-NP
cell	cell	NN	I-NP
proliferation	proliferation	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
4A	4A	NNP	0
)	)	-RRB-	0
.	.	.	0
Among	Among	IN	0
apoptosis	apoptosis	JJ	B-NP
transcript	transcript	NN	I-NP
with	with	IN	0
altered	altered	JJ	0
expression	expression	NN	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
8B	8B	NNP	0
)	)	-RRB-	0
,	,	,	0
PNN	PNN	NNP	B-NP
analysis	analysis	NN	I-NP
demonstrates	demonstrates	VBZ	0
that	that	DT	0
downregulated	downregulated	JJ	B-NP
Caspase	Caspase	NNP	I-NP
1	1	CD	0
transcript	transcript	NN	0
,	,	,	0
almost	almost	RB	0
alone	alone	RB	0
,	,	,	0
best	best	RBS	0
discriminates	discriminates	JJ	0
control	control	NN	0
from	from	IN	0
sn50-treated	sn50-treated	NN	B-NP
explant	explant	NN	I-NP
.	.	.	0
Caspase	Caspase	NNP	B-NP
1	1	CD	0
activates	activates	CD	0
Caspase	Caspase	CD	B-NP
3	3	CD	0
and	and	CC	0
appears	appears	VBZ	0
to	to	TO	0
promote	promote	VB	0
production	production	NN	0
of	of	IN	0
the	the	DT	0
cytokine	cytokine	JJ	B-NP
IL-1β	IL-1β	NN	I-NP
,	,	,	0
which	which	WDT	0
upregulates	upregulates	VBZ	0
the	the	DT	0
transcription	transcription	NN	B-NP
of	of	IN	0
both	both	DT	0
caspa	caspa	NN	B-NP
1	1	CD	0
and	and	CC	0
3	3	CD	0
,	,	,	0
additionally	additionally	FW	0
potentiating	potentiating	NN	B-NP
apoptosi	apoptosi	NN	I-NP
[	[	-LRB-	0
37	37	CD	0
38	38	CD	0
]	]	-RRB-	0
.	.	.	0
Thus	Thus	RB	0
,	,	,	0
this	this	DT	0
caspase	caspase	JJ	B-NP
gene	gene	NN	I-NP
expression	expression	NN	I-NP
regulatory	regulatory	JJ	I-NP
mechanism	mechanism	NN	I-NP
would	would	MD	0
likely	likely	RB	0
be	be	VB	0
diminished	diminished	VBN	0
in	in	IN	0
sn50-treated	sn50-treated	NN	B-NP
explant	explant	NN	I-NP
were	were	VBD	0
they	they	PRP	0
allowed	allowed	VBD	0
to	to	TO	0
develop	develop	VB	0
further	further	RBR	0
in	in	IN	0
culture	culture	NN	0
.	.	.	0
Contemporaneous	Contemporaneous	JJ	B-NP
proteome	proteome	JJ	I-NP
analysis	analysis	NN	I-NP
provides	provides	VBZ	0
a	a	DT	0
very	very	RB	0
different	different	JJ	0
profile	profile	NN	0
(	(	-LRB-	0
see	see	VB	0
Table	Table	NNP	0
2and	2and	NNP	0
text	text	NN	0
below	below	IN	0
)	)	-RRB-	0
.	.	.	0
Although	Although	IN	0
many	many	JJ	0
"Ras	"Ras	NNP	0
/	/	NNP	0
Raf	Raf	NNP	0
"	"	''	0
growth	growth	NN	B-NP
factor	factor	NN	I-NP
pathway	pathway	NN	I-NP
transcript	transcript	NN	I-NP
were	were	VBD	0
upregulated	upregulated	NNS	0
(	(	-LRB-	0
Table	Table	NNP	0
1	1	CD	0
)	)	-RRB-	0
,	,	,	0
as	as	IN	0
a	a	DT	0
group	group	NN	0
they	they	PRP	0
were	were	VBD	0
poor	poor	JJ	0
predictors	predictors	NN	0
of	of	IN	0
SMG	SMG	NNP	B-NP
phenotypa	phenotypa	NN	I-NP
(	(	-LRB-	0
control	control	NN	B-NP
v.	v.	CC	I-NP
SN50-treated	SN50-treated	CD	B-NP
)	)	-RRB-	0
.	.	.	0
PNN	PNN	NNP	B-NP
analysis	analysis	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
9A	9A	NNP	0
)	)	-RRB-	0
shows	shows	VBZ	0
that	that	IN	0
only	only	RB	0
IGF2	IGF2	CD	B-NP
,	,	,	0
IGF2R	IGF2R	NNP	0
,	,	,	0
and	and	CC	0
IGFBP3	IGFBP3	NNP	B-NP
are	are	VBP	0
best	best	RB	0
at	at	IN	0
discriminating	discriminating	VBG	B-NP
control	control	NN	I-NP
from	from	IN	0
sn50-treated	sn50-treated	NN	B-NP
explant	explant	NN	I-NP
.	.	.	0
TGF-β1	TGF-β1	NNP	B-NP
and	and	CC	0
TGF-β2	TGF-β2	RB	B-NP
show	show	VB	0
a	a	DT	0
2-fold	2-fold	JJ	0
increase	increase	NN	0
(	(	-LRB-	0
Table	Table	NNP	0
1	1	CD	0
)	)	-RRB-	0
which	which	WDT	0
is	is	VBZ	0
not	not	RB	0
unexpected	unexpected	JJ	0
given	given	VBN	0
that	that	IN	0
transforming	transforming	VBG	B-NP
growth	growth	NN	I-NP
factor	factor	NN	I-NP
β	β	NN	I-NP
and	and	CC	0
NF-κB	NF-κB	NN	B-NP
are	are	VBP	0
found	found	VBN	0
to	to	TO	0
be	be	VB	0
inversely	inversely	RB	0
proportional	proportional	VBN	0
to	to	TO	0
one	one	CD	0
another	another	DT	0
[	[	-LRB-	0
39	39	CD	0
]	]	-RRB-	0
.	.	.	0
Nevertheless	Nevertheless	RB	0
,	,	,	0
among	among	IN	0
the	the	DT	0
tgf-β	tgf-β	NN	B-NP
family	family	NN	I-NP
transcript	transcript	NN	I-NP
and	and	CC	0
others	others	NNS	0
related	related	VBN	0
to	to	TO	0
their	their	PRP$	0
expression	expression	NN	0
and	and	CC	0
signal	signal	NN	B-NP
transduction	transduction	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
9B	9B	NNP	0
)	)	-RRB-	0
,	,	,	0
BMP1	BMP1	NNP	B-NP
,	,	,	0
BMP3b	BMP3b	NNP	0
,	,	,	0
BMP8a	BMP8a	NNP	0
,	,	,	0
Smad7	Smad7	NNP	B-NP
,	,	,	0
and	and	CC	0
glucocorticoid	glucocorticoid	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
receptor	receptor	NN	I-NP
best	best	RB	0
discriminate	discriminate	JJ	0
control	control	NN	0
from	from	IN	0
sn50-treated	sn50-treated	NN	B-NP
explant	explant	NN	I-NP
.	.	.	0
BMPs	BMPs	JJ	0
inhibit	inhibit	JJ	0
cell	cell	NN	0
proliferation	proliferation	NN	0
via	via	IN	0
downstream	downstream	CD	0
Smad1	Smad1	CD	B-NP
/	/	CD	0
5	5	CD	0
/	/	CD	0
8	8	CD	0
proteins	proteins	NNS	0
whereas	whereas	IN	0
Smad7	Smad7	CD	B-NP
inhibits	inhibits	CD	0
transforming	transforming	VBG	B-NP
growth	growth	NN	I-NP
factor	factor	NN	I-NP
β	β	NN	I-NP
and	and	CC	0
activin	activin	JJ	0
signaling	signaling	NNS	0
(	(	-LRB-	0
Fig.	Fig.	CD	0
1	1	CD	0
)	)	-RRB-	0
.	.	.	0
This	This	DT	0
inhibition	inhibition	NN	0
of	of	IN	0
TGF-β	TGF-β	NN	B-NP
/	/	NN	I-NP
activin	activin	NN	I-NP
signaling	signaling	FW	0
is	is	VBZ	0
modulated	modulated	VBN	0
through	through	IN	0
smad7	smad7	NN	B-NP
nf-κb-dependent	nf-κb-dependent	NN	I-NP
inhibition	inhibition	NN	I-NP
[	[	-LRB-	0
40	40	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
addition	addition	NN	B-NP
,	,	,	0
there	there	EX	0
is	is	VBZ	0
a	a	DT	0
negative	negative	JJ	B-NP
feedback	feedback	NN	I-NP
between	between	IN	0
NF-κB	NF-κB	JJ	B-NP
and	and	CC	0
Smad7	Smad7	NNP	B-NP
;	;	:	0
activated	activated	VBN	B-NP
NF-κB	NF-κB	NN	I-NP
inhibits	inhibits	FW	0
Smad7	Smad7	NN	B-NP
promotor	promotor	NN	I-NP
activity	activity	NN	I-NP
[	[	-LRB-	0
41	41	CD	0
]	]	-RRB-	0
whereas	whereas	FW	0
Smad7	Smad7	NN	B-NP
inhibits	inhibits	FW	0
NF-κB	NF-κB	NN	B-NP
activation	activation	NN	I-NP
and	and	CC	0
potentiates	potentiates	JJ	B-NP
apoptosi	apoptosi	NN	I-NP
[	[	-LRB-	0
42	42	CD	0
]	]	-RRB-	0
.	.	.	0
Curiously	Curiously	NNP	0
,	,	,	0
the	the	DT	0
relative	relative	JJ	B-NP
importance	importance	NN	I-NP
of	of	IN	0
increased	increased	JJ	0
Smad7	Smad7	CD	B-NP
expression	expression	NN	I-NP
is	is	VBZ	0
20	20	CD	0
times	times	NNS	0
greater	greater	JJR	0
than	than	IN	0
that	that	DT	0
of	of	IN	0
Smad1	Smad1	CD	B-NP
/	/	CD	0
5	5	CD	0
vi	vi	NNP	B-NP
defining	defining	CD	0
the	the	DT	0
nf-κb-inhibited	nf-κb-inhibited	NN	B-NP
explant	explant	NN	I-NP
.	.	.	0
It	It	PRP	0
is	is	VBZ	0
likely	likely	RB	0
that	that	IN	0
,	,	,	0
in	in	IN	0
the	the	DT	0
absence	absence	NN	B-NP
of	of	IN	0
NF-κB	NF-κB	NNP	0
's	's	POS	0
negative	negative	JJ	B-NP
regulation	regulation	NN	I-NP
,	,	,	0
Smad7	Smad7	CD	B-NP
signaling	signaling	NN	I-NP
is	is	VBZ	0
upregulated	upregulated	VBN	0
,	,	,	0
thereby	thereby	RB	0
sensitizing	sensitizing	JJ	0
cells	cells	NNS	0
to	to	TO	0
apoptosis	apoptosis	VB	0
.	.	.	0
Finally	Finally	RB	0
,	,	,	0
the	the	DT	0
nearly	nearly	RB	0
2-fold	2-fold	CD	0
decrease	decrease	NN	0
in	in	IN	0
glucocorticoid	glucocorticoid	JJ	B-NP
receptor	receptor	NN	I-NP
(	(	-LRB-	0
GR	GR	NNP	B-NP
)	)	-RRB-	0
is	is	VBZ	0
also	also	RB	0
of	of	IN	0
high	high	JJ	0
relative	relative	JJ	B-NP
importance	importance	NN	I-NP
in	in	IN	0
defining	defining	VBG	0
the	the	DT	0
SN50-treated	SN50-treated	CD	B-NP
phenotypa	phenotypa	NN	I-NP
(	(	-LRB-	0
Table	Table	NNP	0
1	1	CD	0
)	)	-RRB-	0
.	.	.	0
glucocorticoid	glucocorticoid	NN	B-NP
(	(	-LRB-	0
CORT	CORT	NNP	B-NP
)	)	-RRB-	0
function	function	NN	0
through	through	IN	0
the	the	DT	0
glucocorticoid	glucocorticoid	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
receptor	receptor	NN	I-NP
to	to	TO	0
both	both	DT	0
activate	activate	JJ	0
specific	specific	JJ	0
gene	gene	NN	B-NP
expression	expression	NN	I-NP
as	as	IN	0
well	well	RB	0
as	as	IN	0
transrepress	transrepress	JJ	B-NP
NF-κB	NF-κB	NN	I-NP
[	[	-LRB-	0
41	41	CD	0
]	]	-RRB-	0
.	.	.	0
Since	Since	IN	0
glucocorticoid	glucocorticoid	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
receptor	receptor	NN	I-NP
confers	confers	VBZ	0
this	this	DT	0
latter	latter	JJ	0
effect	effect	NN	0
by	by	IN	0
associating	associating	VBG	0
through	through	IN	0
protein-protein	protein-protein	JJ	B-NP
interaction	interaction	NN	I-NP
with	with	IN	0
NF-κB	NF-κB	JJ	B-NP
bound	bound	NN	I-NP
at	at	IN	0
κb	κb	NN	B-NP
response	response	NN	I-NP
element	element	NN	I-NP
[	[	-LRB-	0
43	43	CD	0
44	44	CD	0
45	45	CD	0
46	46	CD	0
47	47	CD	0
]	]	-RRB-	0
,	,	,	0
it	it	PRP	0
is	is	VBZ	0
important	important	JJ	0
to	to	TO	0
also	also	RB	0
evaluate	evaluate	VB	0
changes	changes	NNS	0
in	in	IN	0
gr	gr	NN	B-NP
protein	protein	NN	I-NP
level	level	JJ	I-NP
(	(	-LRB-	0
see	see	VB	0
below	below	IN	0
)	)	-RRB-	0
.	.	.	0
Further	Further	RB	0
,	,	,	0
we	we	PRP	0
utilized	utilized	VBD	0
PNN	PNN	NNP	B-NP
analysis	analysis	NN	I-NP
to	to	TO	0
determine	determine	VB	0
the	the	DT	0
iterated	iterated	JJ	0
composite	composite	JJ	0
relative	relative	JJ	B-NP
importance	importance	NN	I-NP
among	among	IN	0
Connections	Connections	NNP	B-NP
Map	Map	NNP	I-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
1	1	CD	0
)	)	-RRB-	0
transcripts	transcripts	NNS	0
which	which	WDT	0
have	have	VBP	0
altered	altered	VBN	B-NP
expression	expression	NN	I-NP
as	as	IN	0
a	a	DT	0
consequence	consequence	NN	0
of	of	IN	0
inhibition	inhibition	NN	0
of	of	IN	0
NF-κB	NF-κB	JJ	B-NP
translocation	translocation	NN	I-NP
into	into	IN	0
the	the	DT	0
nucleus	nucleus	NN	B-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
10	10	CD	0
)	)	-RRB-	0
.	.	.	0
That	That	WDT	0
is	is	VBZ	0
,	,	,	0
we	we	PRP	0
then	then	RB	0
subjected	subjected	VBN	0
those	those	DT	0
transcripts	transcripts	NNS	0
with	with	IN	0
altered	altered	JJ	0
expression	expression	NN	0
in	in	IN	0
each	each	DT	0
group	group	NN	0
(	(	-LRB-	0
cell	cell	NN	B-NP
cycle	cycle	NN	I-NP
,	,	,	0
apoptosi	apoptosi	NN	B-NP
,	,	,	0
Ras	Ras	NNP	B-NP
/	/	NNP	I-NP
Raf	Raf	NNP	I-NP
,	,	,	0
TGF-β	TGF-β	JJ	B-NP
family	family	NN	I-NP
)	)	-RRB-	0
previously	previously	RB	0
shown	shown	VBN	0
in	in	IN	0
Figures	Figures	NNP	0
7and	7and	CD	0
8	8	CD	0
to	to	TO	0
be	be	VB	0
relatively	relatively	RB	0
important	important	JJ	0
in	in	IN	0
defining	defining	VBG	0
the	the	DT	0
SN50	SN50	NNP	B-NP
SMG	SMG	NNP	I-NP
phenotype	phenotype	VBD	0
to	to	TO	0
further	further	RBR	0
PNN	PNN	JJ	B-NP
analysis	analysis	NN	I-NP
.	.	.	0
This	This	DT	0
transciptomic	transciptomic	JJ	B-NP
analysis	analysis	NN	I-NP
is	is	VBZ	0
a	a	DT	0
time-bound	time-bound	JJ	B-NP
"snapshot	"snapshot	NN	0
"	"	''	0
in	in	IN	0
which	which	WDT	0
gene	gene	NN	B-NP
expression	expression	NN	I-NP
is	is	VBZ	0
indicative	indicative	VBN	0
of	of	IN	0
possible	possible	JJ	0
future	future	JJ	0
protein	protein	NN	B-NP
expression	expression	NN	I-NP
.	.	.	0
It	It	PRP	0
is	is	VBZ	0
instructive	instructive	VBN	0
that	that	IN	0
,	,	,	0
of	of	IN	0
the	the	DT	0
53	53	CD	0
Connections	Connections	NNP	0
map	map	NN	B-NP
transcript	transcript	NN	I-NP
with	with	IN	0
altered	altered	JJ	0
expression	expression	NN	0
(	(	-LRB-	0
Table	Table	NNP	0
1	1	CD	0
)	)	-RRB-	0
,	,	,	0
4	4	CD	0
genes	genes	NNS	0
of	of	IN	0
diverse	diverse	JJ	B-NP
pathway	pathway	NN	I-NP
but	but	CC	0
overlapping	overlapping	NNS	0
function	function	VBP	0
best	best	RBS	0
discriminate	discriminate	JJ	0
control	control	NN	0
from	from	IN	0
sn50-treated	sn50-treated	NN	B-NP
explant	explant	NN	I-NP
:	:	:	0
PCNA	PCNA	NNP	B-NP
,	,	,	0
glucocorticoid	glucocorticoid	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
receptor	receptor	NN	I-NP
,	,	,	0
BMP1	BMP1	NNP	B-NP
,	,	,	0
BMP3b	BMP3b	NNP	0
.	.	.	0
The	The	DT	0
declining	declining	VBG	B-NP
PCNA	PCNA	NNP	I-NP
and	and	CC	0
glucocorticoid	glucocorticoid	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
receptor	receptor	NN	I-NP
reflect	reflect	VBP	0
the	the	DT	0
sharp	sharp	JJ	0
decline	decline	NN	0
in	in	IN	0
cell	cell	NN	0
proliferation	proliferation	NN	0
and	and	CC	0
branching	branching	NNS	0
;	;	:	0
the	the	DT	0
increasing	increasing	VBG	B-NP
BMP1	BMP1	NNP	I-NP
and	and	CC	0
BMP3b	BMP3b	NNP	0
similarly	similarly	RB	0
reflects	reflects	VBZ	0
inhibition	inhibition	VBN	0
of	of	IN	0
cell	cell	NN	0
proliferation	proliferation	NN	0
(	(	-LRB-	0
Fig.	Fig.	CD	0
1	1	CD	0
)	)	-RRB-	0
.	.	.	0
Proteomic	Proteomic	NNP	0
analysis	analysis	VBD	0
Our	Our	PRP$	0
cDNA	cDNA	JJ	0
array	array	NN	0
analysis	analysis	NN	0
provides	provides	VBZ	0
a	a	DT	0
good	good	JJ	0
first	first	JJ	0
approximation	approximation	NN	0
of	of	IN	0
likely	likely	JJ	0
protein	protein	NN	0
differences	differences	NNS	0
.	.	.	0
However	However	RB	0
,	,	,	0
one	one	CD	0
cannot	cannot	JJ	0
extrapolate	extrapolate	NN	0
from	from	IN	0
mRNA	mRNA	JJ	B-NP
abundance	abundance	NN	I-NP
to	to	TO	0
relevant	relevant	JJ	0
protein	protein	NN	B-NP
level	level	JJ	I-NP
[	[	-LRB-	0
48	48	CD	0
]	]	-RRB-	0
.	.	.	0
A	A	DT	0
recent	recent	JJ	0
study	study	NN	0
by	by	IN	0
Aebersole	Aebersole	NNP	B-NP
and	and	CC	0
coworker	coworker	NN	B-NP
[	[	-LRB-	0
48	48	CD	0
]	]	-RRB-	0
analyzing	analyzing	VBG	B-NP
yeast	yeast	NN	I-NP
protein	protein	NN	I-NP
and	and	CC	0
mRNA	mRNA	JJ	B-NP
abundance	abundance	NN	I-NP
clearly	clearly	RB	0
showed	showed	VBD	0
that	that	DT	0
mrna	mrna	NN	B-NP
transcript	transcript	NN	I-NP
level	level	JJ	I-NP
are	are	VBP	0
poor	poor	JJ	0
predictors	predictors	NN	0
of	of	IN	0
protein	protein	NN	B-NP
expression	expression	NN	I-NP
.	.	.	0
They	They	PRP	0
demonstrate	demonstrate	VBP	0
that	that	IN	0
some	some	DT	0
genes	genes	NNS	0
with	with	IN	0
comparable	comparable	JJ	0
mrna	mrna	NN	B-NP
level	level	JJ	I-NP
exhibited	exhibited	VBP	0
a	a	DT	0
20-fold	20-fold	JJ	0
difference	difference	NN	0
in	in	IN	0
their	their	PRP$	0
protein	protein	NN	B-NP
expression	expression	NN	I-NP
while	while	IN	0
mrna	mrna	NN	B-NP
level	level	JJ	I-NP
of	of	IN	0
comparable	comparable	JJ	0
protein	protein	NN	B-NP
expression	expression	NN	I-NP
varied	varied	VBD	0
as	as	RB	0
much	much	RB	0
as	as	IN	0
30-fold	30-fold	CD	0
.	.	.	0
Thus	Thus	RB	0
,	,	,	0
we	we	PRP	0
next	next	RB	0
analyzed	analyzed	VBD	B-NP
SN50-treated	SN50-treated	CD	I-NP
and	and	CC	0
control	control	NN	B-NP
E15	E15	CD	I-NP
+	+	CD	0
2	2	CD	0
submandibular	submandibular	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
salivary	salivary	JJ	I-NP
gland	gland	NN	I-NP
explants	explants	VBP	0
using	using	VBG	0
2-d	2-d	NN	B-NP
western	western	JJ	I-NP
multiprotein	multiprotein	NN	I-NP
array	array	NN	I-NP
to	to	TO	0
determine	determine	VB	0
protein	protein	NN	B-NP
difference	difference	NN	I-NP
.	.	.	0
This	This	DT	0
technique	technique	NN	0
allows	allows	VBZ	0
for	for	IN	0
the	the	DT	0
densitometric	densitometric	JJ	B-NP
analysis	analysis	NN	I-NP
of	of	IN	0
about	about	IN	0
600	600	CD	0
signal	signal	NN	B-NP
transduction	transduction	NN	I-NP
and	and	CC	0
other	other	JJ	0
proteins	proteins	NNS	0
simultaneously	simultaneously	RB	0
in	in	IN	0
each	each	DT	0
independent	independent	JJ	0
sample	sample	NN	0
(	(	-LRB-	0
Fig.	Fig.	CD	0
11	11	CD	0
)	)	-RRB-	0
.	.	.	0
As	As	RB	0
shown	shown	VBN	0
in	in	IN	0
Table	Table	NNP	0
2	2	CD	0
,	,	,	0
we	we	PRP	0
find	find	VBP	0
18	18	CD	0
proteins	proteins	NNS	0
which	which	WDT	0
have	have	VBP	0
both	both	PDT	0
a	a	DT	0
1.5-fold	1.5-fold	NNP	0
or	or	CC	0
greater	greater	JJR	0
change	change	NN	0
with	with	IN	0
NF-κB	NF-κB	JJ	B-NP
inhibition	inhibition	NN	I-NP
and	and	CC	0
are	are	VBP	0
specifically	specifically	RB	0
related	related	VBN	0
to	to	TO	0
the	the	DT	0
Connections	Connections	NNP	B-NP
Map	Map	NNP	I-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
1	1	CD	0
)	)	-RRB-	0
.	.	.	0
They	They	PRP	0
include	include	VBP	0
signal	signal	NN	B-NP
transduction	transduction	NN	I-NP
,	,	,	0
cell	cell	NN	B-NP
cycle	cycle	NN	I-NP
,	,	,	0
and	and	CC	0
apoptosis	apoptosis	JJ	B-NP
protein	protein	NN	I-NP
that	that	WDT	0
are	are	VBP	0
either	either	RB	0
directly	directly	RB	0
or	or	CC	0
indirectly	indirectly	RB	0
downstream	downstream	VBN	0
from	from	IN	0
tumor	tumor	NN	B-NP
necrosi	necrosi	NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
factor	factor	NN	I-NP
activation	activation	NN	I-NP
,	,	,	0
IL-6	IL-6	NNP	B-NP
,	,	,	0
EGF	EGF	NNP	B-NP
,	,	,	0
IGF	IGF	NNP	B-NP
,	,	,	0
and	and	CC	0
signaling	signaling	VBG	B-NP
pathway	pathway	NN	I-NP
fgf	fgf	NN	I-NP
.	.	.	0
The	The	DT	0
significant	significant	JJ	0
decline	decline	NN	0
in	in	IN	0
PCNA	PCNA	NNP	B-NP
protein	protein	NN	I-NP
(	(	-LRB-	0
Table	Table	NNP	0
2	2	CD	0
)	)	-RRB-	0
is	is	VBZ	0
consistent	consistent	JJ	0
with	with	IN	0
the	the	DT	0
significant	significant	JJ	0
decline	decline	NN	0
in	in	IN	0
PCNA	PCNA	NNP	B-NP
transcript	transcript	NN	I-NP
(	(	-LRB-	0
Table	Table	NNP	0
1	1	CD	0
)	)	-RRB-	0
and	and	CC	0
PCNA-defined	PCNA-defined	JJ	B-NP
cell	cell	NN	I-NP
proliferation	proliferation	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
4A	4A	NNP	0
)	)	-RRB-	0
.	.	.	0
pnn	pnn	NN	B-NP
analysis	analysis	NN	I-NP
show	show	NN	I-NP
that	that	IN	0
among	among	IN	0
cell	cell	NN	0
cycle	cycle	NN	0
proteins	proteins	NNS	0
with	with	IN	0
altered	altered	JJ	0
expression	expression	NN	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
12A	12A	NNP	0
)	)	-RRB-	0
,	,	,	0
the	the	DT	0
increased	increased	JJ	0
expression	expression	NN	0
of	of	IN	0
Chk1	Chk1	NNP	B-NP
,	,	,	0
Chk2	Chk2	NNP	B-NP
,	,	,	0
and	and	CC	0
E2F1	E2F1	CD	0
best	best	JJS	0
discriminates	discriminates	JJ	0
control	control	NN	0
from	from	IN	0
sn50-treated	sn50-treated	NN	B-NP
explant	explant	NN	I-NP
.	.	.	0
Of	Of	IN	0
particular	particular	JJ	0
interest	interest	NN	0
is	is	VBZ	0
E2F1	E2F1	CD	0
.	.	.	0
Among	Among	IN	0
the	the	DT	0
five	five	CD	0
known	known	VBN	0
mammalian	mammalian	JJ	0
E2Fs	E2Fs	NN	0
,	,	,	0
the	the	DT	0
ability	ability	NN	0
to	to	TO	0
induce	induce	VB	0
apoptosis	apoptosis	NN	0
is	is	VBZ	0
unique	unique	JJ	0
to	to	TO	0
E2F1	E2F1	CD	0
[	[	-LRB-	0
49	49	CD	0
]	]	-RRB-	0
.	.	.	0
Overexpression	Overexpression	NNP	0
of	of	IN	0
E2F1	E2F1	CD	0
in	in	IN	0
several	several	JJ	0
cell	cell	NN	0
lines	lines	NNS	0
results	results	NNS	0
in	in	IN	0
G	G	NNP	0
2	2	CD	0
arrest	arrest	NN	0
,	,	,	0
as	as	RB	0
well	well	RB	0
as	as	IN	0
apoptosi	apoptosi	NN	B-NP
via	via	IN	0
p53-dependent	p53-dependent	NNP	B-NP
and	and	CC	0
p53-independent	p53-independent	CD	B-NP
pathway	pathway	NN	I-NP
[	[	-LRB-	0
50	50	CD	0
51	51	CD	0
52	52	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
presence	presence	NN	0
of	of	IN	0
a	a	DT	0
dysplastic	dysplastic	JJ	B-NP
SMG	SMG	NNP	I-NP
phenotype	phenotype	NN	I-NP
in	in	IN	0
E2f1	E2f1	CD	0
-	-	:	0
/	/	NNP	0
-mice	-mice	NNP	0
indicates	indicates	VBZ	0
that	that	IN	0
E2F1	E2F1	NNP	0
plays	plays	VBZ	0
an	an	DT	0
important	important	JJ	0
role	role	NN	0
during	during	IN	0
SMG	SMG	NNP	B-NP
development	development	NN	I-NP
[	[	-LRB-	0
53	53	CD	0
]	]	-RRB-	0
.	.	.	0
Moreover	Moreover	RB	0
,	,	,	0
E2F1	E2F1	CD	0
overexpression	overexpression	NN	0
in	in	IN	0
human	human	JJ	B-NP
salivary	salivary	JJ	I-NP
gland	gland	NN	I-NP
(	(	-LRB-	0
HSG	HSG	NNP	B-NP
)	)	-RRB-	0
cells	cells	NNS	0
diverted	diverted	VBN	0
these	these	DT	0
cells	cells	NNS	0
into	into	IN	0
an	an	DT	0
apoptotic	apoptotic	JJ	B-NP
pathway	pathway	NN	I-NP
[	[	-LRB-	0
54	54	CD	0
]	]	-RRB-	0
.	.	.	0
Among	Among	IN	0
apoptosis	apoptosis	JJ	B-NP
protein	protein	NN	I-NP
with	with	IN	0
altered	altered	JJ	0
expression	expression	NN	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
12B	12B	NNP	0
)	)	-RRB-	0
,	,	,	0
PNN	PNN	NNP	B-NP
analysis	analysis	NN	I-NP
demonstrates	demonstrates	VBZ	0
that	that	DT	0
increased	increased	JJ	0
expression	expression	NN	0
of	of	IN	0
FAF	FAF	NNP	B-NP
and	and	CC	0
Caspase	Caspase	NNP	B-NP
6	6	CD	0
best	best	JJS	0
discriminates	discriminates	JJ	0
control	control	NN	0
from	from	IN	0
sn50-treated	sn50-treated	NN	B-NP
explant	explant	NN	I-NP
.	.	.	0
Caspase	Caspase	NNP	B-NP
6	6	CD	0
is	is	VBZ	0
activated	activated	VBN	0
by	by	IN	0
active	active	JJ	0
Caspase	Caspase	NNP	B-NP
3	3	CD	0
and	and	CC	0
in	in	IN	0
turn	turn	NN	0
cleaves	cleaves	NN	0
lamin	lamin	NN	B-NP
,	,	,	0
resulting	resulting	VBG	0
in	in	IN	0
nuclear	nuclear	JJ	0
membrane	membrane	JJ	B-NP
fragmentation	fragmentation	NN	I-NP
[	[	-LRB-	0
55	55	CD	0
]	]	-RRB-	0
.	.	.	0
FAF	FAF	NNP	B-NP
interacts	interacts	NN	0
with	with	IN	0
the	the	DT	0
fa	fa	NN	B-NP
receptor	receptor	NN	I-NP
cytoplasmic	cytoplasmic	JJ	I-NP
domain	domain	NN	I-NP
to	to	TO	0
potentiate	potentiate	VB	0
Fas-mediated	Fas-mediated	JJ	0
apoptosi	apoptosi	NN	B-NP
[	[	-LRB-	0
56	56	CD	0
57	57	CD	0
]	]	-RRB-	0
.	.	.	0
Thus	Thus	RB	0
,	,	,	0
the	the	DT	0
up-regulated	up-regulated	JJ	0
cell	cell	NN	0
cycle	cycle	NN	0
inhibitors	inhibitors	NNS	0
and	and	CC	0
apoptotic	apoptotic	JJ	B-NP
protein	protein	NN	I-NP
clearly	clearly	RB	0
favor	favor	VB	0
cell	cell	NN	0
cycle	cycle	NN	0
arrest	arrest	NN	0
and	and	CC	0
death	death	NN	0
.	.	.	0
Among	Among	IN	0
signal	signal	NN	B-NP
transduction	transduction	NN	I-NP
protein	protein	NN	I-NP
with	with	IN	0
altered	altered	JJ	0
expression	expression	NN	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
12C	12C	NNP	0
)	)	-RRB-	0
,	,	,	0
pnn	pnn	NN	B-NP
analysis	analysis	NN	I-NP
show	show	NN	I-NP
that	that	IN	0
members	members	NNS	0
of	of	IN	0
all	all	DT	0
three	three	CD	0
growth	growth	NN	B-NP
factor	factor	NN	I-NP
pathway	pathway	NN	I-NP
(	(	-LRB-	0
Ras	Ras	NNP	B-NP
/	/	NNP	I-NP
Raf	Raf	NNP	I-NP
;	;	:	0
JAK	JAK	NNP	B-NP
/	/	NNP	I-NP
STAT	STAT	NNP	I-NP
;	;	:	0
jun	jun	NNP	B-NP
n	n	NN	I-NP
terminal	terminal	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
kinase	kinase	NN	I-NP
)	)	-RRB-	0
have	have	VBP	0
high	high	JJ	0
relative	relative	JJ	B-NP
importance	importance	NN	I-NP
in	in	IN	0
discriminating	discriminating	VBG	B-NP
control	control	NN	I-NP
from	from	IN	0
sn50-treated	sn50-treated	NN	B-NP
explant	explant	NN	I-NP
.	.	.	0
Of	Of	IN	0
particular	particular	JJ	0
note	note	NN	0
are	are	VBP	0
c-Raf	c-Raf	JJ	B-NP
,	,	,	0
ERK2	ERK2	NNP	B-NP
,	,	,	0
and	and	CC	0
JAK1	JAK1	NNP	B-NP
.	.	.	0
Raf	Raf	NNP	B-NP
plays	plays	VBZ	0
a	a	DT	0
key	key	JJ	B-NP
role	role	NN	I-NP
in	in	IN	0
the	the	DT	0
Ras	Ras	NNP	0
signaling	signaling	VBG	B-NP
pathway	pathway	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
1	1	CD	0
)	)	-RRB-	0
.	.	.	0
That	That	IN	0
ERK2	ERK2	NNP	B-NP
is	is	VBZ	0
of	of	IN	0
very	very	RB	0
high	high	JJ	0
relative	relative	JJ	B-NP
importance	importance	NN	I-NP
is	is	VBZ	0
consistent	consistent	JJ	0
with	with	IN	0
the	the	DT	0
observation	observation	NN	0
that	that	IN	0
the	the	DT	0
MAPK	MAPK	NNP	B-NP
/	/	NNP	I-NP
ERK	ERK	NNP	I-NP
overrides	overrides	NNS	0
apoptotic	apoptotic	VBP	0
signaling	signaling	VBG	0
from	from	IN	0
Fas	Fas	NNP	0
,	,	,	0
tumor	tumor	NN	B-NP
necrosi	necrosi	NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
factor	factor	NN	I-NP
and	and	CC	0
trail	trail	NN	B-NP
receptor	receptor	NN	I-NP
[	[	-LRB-	0
58	58	CD	0
]	]	-RRB-	0
.	.	.	0
It	It	PRP	0
appears	appears	VBZ	0
that	that	IN	0
effectors	effectors	VBG	0
apart	apart	RP	0
from	from	IN	0
the	the	DT	0
MAPK	MAPK	NNP	B-NP
/	/	NNP	I-NP
ERK	ERK	NNP	I-NP
pathway	pathway	NN	I-NP
may	may	MD	0
also	also	RB	0
mediate	mediate	VB	0
the	the	DT	0
c-raf	c-raf	NN	B-NP
anti-apoptotic	anti-apoptotic	JJ	I-NP
function	function	NN	I-NP
[	[	-LRB-	0
55a	55a	NNP	0
]	]	-RRB-	0
.	.	.	0
Further	Further	RB	0
,	,	,	0
both	both	CC	0
the	the	DT	0
SHP-2	SHP-2	NNP	B-NP
/	/	NNP	0
Ras	Ras	NNP	0
and	and	CC	0
JAK	JAK	NNP	B-NP
/	/	CD	0
stat3	stat3	NN	B-NP
pathway	pathway	NN	I-NP
are	are	VBP	0
activated	activated	VBN	0
by	by	IN	0
IL-6R	IL-6R	CD	B-NP
/	/	CD	0
gp130	gp130	CD	B-NP
signaling	signaling	NNS	0
(	(	-LRB-	0
Fig.	Fig.	CD	0
1	1	CD	0
)	)	-RRB-	0
.	.	.	0
Moreover	Moreover	RB	0
,	,	,	0
it	it	PRP	0
is	is	VBZ	0
especially	especially	RB	0
noteworthy	noteworthy	VBN	0
that	that	IN	0
the	the	DT	0
nearly	nearly	RB	0
2-fold	2-fold	CD	0
decline	decline	NN	0
of	of	IN	0
glucocorticoid	glucocorticoid	JJ	B-NP
receptor	receptor	NN	I-NP
(	(	-LRB-	0
GR	GR	NNP	B-NP
)	)	-RRB-	0
(	(	-LRB-	0
Table	Table	NNP	0
2	2	CD	0
)	)	-RRB-	0
is	is	VBZ	0
also	also	RB	0
of	of	IN	0
very	very	RB	0
high	high	JJ	0
relative	relative	JJ	B-NP
importance	importance	NN	I-NP
in	in	IN	0
defining	defining	JJ	0
nf-κb	nf-κb	NN	B-NP
smg	smg	NN	I-NP
deprived	deprived	NN	I-NP
nuclear	nuclear	JJ	0
translocation	translocation	NN	B-NP
.	.	.	0
As	As	RB	0
noted	noted	VBD	0
above	above	RB	0
,	,	,	0
CORT	CORT	NNP	B-NP
/	/	NNP	I-NP
GR	GR	NNP	I-NP
binding	binding	VBD	0
both	both	DT	0
activates	activates	JJ	0
specific	specific	JJ	0
gene	gene	NN	B-NP
expression	expression	NN	I-NP
and	and	CC	0
transrepresses	transrepresses	JJ	B-NP
NF-κB	NF-κB	NN	I-NP
[	[	-LRB-	0
47	47	CD	0
]	]	-RRB-	0
.	.	.	0
To	To	TO	0
repress	repress	VB	0
NF-κB	NF-κB	JJ	B-NP
,	,	,	0
the	the	DT	0
gr	gr	NN	B-NP
associate	associate	JJ	I-NP
through	through	IN	0
protein-protein	protein-protein	JJ	B-NP
interaction	interaction	NN	I-NP
with	with	IN	0
NF-κB	NF-κB	JJ	B-NP
bound	bound	NN	I-NP
at	at	IN	0
κb	κb	NN	B-NP
response	response	NN	I-NP
element	element	NN	I-NP
[	[	-LRB-	0
44	44	CD	0
45	45	CD	0
46	46	CD	0
47	47	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
precise	precise	JJ	0
relationship	relationship	NN	B-NP
between	between	IN	0
decreased	decreased	JJ	0
NF-κB-mediated	NF-κB-mediated	JJ	B-NP
transcription	transcription	NN	I-NP
and	and	CC	0
a	a	DT	0
decreased	decreased	JJ	0
GR	GR	NNP	B-NP
protein	protein	NN	I-NP
expression	expression	NN	I-NP
is	is	VBZ	0
unclear	unclear	JJ	0
.	.	.	0
Nevertheless	Nevertheless	RB	0
,	,	,	0
CORT	CORT	NNP	B-NP
/	/	NNP	I-NP
GR	GR	NNP	I-NP
function	function	NN	I-NP
is	is	VBZ	0
important	important	JJ	0
to	to	TO	0
embryonic	embryonic	JJ	B-NP
smg	smg	NN	I-NP
morphogenesi	morphogenesi	NN	I-NP
[	[	-LRB-	0
60	60	CD	0
]	]	-RRB-	0
.	.	.	0
radioimmunoassay	radioimmunoassay	NN	B-NP
first	first	RB	0
detect	detect	VB	0
SMG	SMG	NNP	B-NP
CORT	CORT	NNP	I-NP
in	in	IN	0
amounts	amounts	NNS	0
>	>	CD	0
2	2	CD	0
pg	pg	CD	B-NP
/	/	CD	I-NP
gland	gland	NN	I-NP
on	on	IN	0
E15	E15	CD	B-NP
;	;	:	0
Western	Western	JJ	0
analysis	analysis	NN	0
first	first	JJ	0
detects	detects	JJ	0
SMG	SMG	NNP	B-NP
GR	GR	NNP	I-NP
on	on	IN	0
E14	E14	NNP	B-NP
(	(	-LRB-	0
0.14	0.14	FW	0
fmol	fmol	NN	B-NP
/	/	NN	I-NP
gland	gland	NN	I-NP
)	)	-RRB-	0
.	.	.	0
By	By	IN	0
E18	E18	NNP	B-NP
,	,	,	0
SMG	SMG	NNP	B-NP
CORT	CORT	NNP	I-NP
has	has	VBZ	0
increased	increased	VBN	0
more	more	JJR	0
than	than	IN	0
50-fold	50-fold	NNP	0
,	,	,	0
and	and	CC	0
SMG	SMG	NNP	B-NP
GR	GR	NNP	I-NP
has	has	VBZ	0
increased	increased	VBN	0
nearly	nearly	RB	0
11-fold	11-fold	CD	0
.	.	.	0
The	The	DT	0
SMG	SMG	NNP	B-NP
GR	GR	NNP	I-NP
is	is	VBZ	0
functional	functional	VBN	0
,	,	,	0
as	as	RB	0
defined	defined	VBN	0
by	by	IN	0
its	its	PRP$	0
ability	ability	NN	B-NP
to	to	TO	0
bind	bind	VB	0
a	a	DT	0
DNA	DNA	NN	B-NP
response	response	NN	I-NP
element	element	NN	I-NP
(	(	-LRB-	0
glucocorticoid	glucocorticoid	NN	B-NP
hormone	hormone	NN	I-NP
responsive	responsive	JJ	I-NP
element	element	NN	I-NP
)	)	-RRB-	0
.	.	.	0
Increasing	Increasing	VBG	B-NP
CORT	CORT	NNP	I-NP
/	/	NNP	I-NP
GR	GR	NNP	I-NP
function	function	NN	I-NP
in	in	IN	0
vivo	vivo	NN	B-NP
is	is	VBZ	0
associated	associated	VBN	0
with	with	IN	0
a	a	DT	0
significant	significant	JJ	0
decline	decline	NN	0
in	in	IN	0
TGF-β	TGF-β	JJ	B-NP
expression	expression	NN	I-NP
and	and	CC	0
a	a	DT	0
significant	significant	JJ	0
increase	increase	NN	0
in	in	IN	0
cell	cell	NN	0
division	division	NN	0
.	.	.	0
submandibular	submandibular	NN	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
salivary	salivary	JJ	I-NP
gland	gland	NN	I-NP
primordia	primordia	VBD	0
cultured	cultured	VBN	0
under	under	IN	0
serumle	serumle	NN	B-NP
,	,	,	0
chemically	chemically	RB	0
defined	defined	VBN	B-NP
condition	condition	NN	I-NP
,	,	,	0
and	and	CC	0
deprived	deprived	VBN	0
of	of	IN	0
CORT	CORT	NNP	B-NP
,	,	,	0
exhibit	exhibit	VBG	0
a	a	DT	0
dramatic	dramatic	JJ	0
decline	decline	NN	0
of	of	IN	0
branching	branching	VBG	B-NP
morphogenesi	morphogenesi	NN	I-NP
submandibular	submandibular	NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
salivary	salivary	JJ	I-NP
gland	gland	NN	I-NP
.	.	.	0
It	It	PRP	0
is	is	VBZ	0
reasonable	reasonable	JJ	0
,	,	,	0
then	then	RB	0
,	,	,	0
to	to	TO	0
assume	assume	VB	0
that	that	IN	0
the	the	DT	0
high	high	JJ	0
relative	relative	JJ	B-NP
importance	importance	NN	I-NP
of	of	IN	0
diminished	diminished	JJ	0
GR	GR	NNP	B-NP
protein	protein	NN	I-NP
expression	expression	NN	I-NP
to	to	TO	0
the	the	DT	0
sn50-treated	sn50-treated	NN	B-NP
smg	smg	NN	I-NP
phenotype	phenotype	NN	I-NP
is	is	VBZ	0
directly	directly	RB	0
related	related	VBN	0
to	to	TO	0
the	the	DT	0
significant	significant	JJ	0
(	(	-LRB-	0
p	p	FW	0
<	<	SYM	0
0.001	0.001	FW	0
)	)	-RRB-	0
decline	decline	NN	0
in	in	IN	0
cell	cell	NN	0
proliferation	proliferation	NN	0
and	and	CC	0
branching	branching	NNS	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
3A	3A	NNP	0
,	,	,	0
B	B	NNP	0
;	;	:	0
Fig.	Fig.	CD	0
4A	4A	CD	0
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
iterated	iterated	JJ	0
composite	composite	JJ	0
relative	relative	JJ	B-NP
importance	importance	NN	I-NP
of	of	IN	0
all	all	DT	0
Connections	Connections	NNP	0
map	map	NN	B-NP
protein	protein	NN	I-NP
with	with	IN	0
altered	altered	JJ	0
expression	expression	NN	0
as	as	IN	0
a	a	DT	0
consequence	consequence	NN	0
of	of	IN	0
NF-κB	NF-κB	JJ	B-NP
inhibition	inhibition	NN	I-NP
was	was	VBD	0
then	then	RB	0
determined	determined	VBN	0
(	(	-LRB-	0
Fig.	Fig.	CD	0
13	13	CD	0
)	)	-RRB-	0
.	.	.	0
This	This	DT	0
proteomic	proteomic	JJ	B-NP
analysis	analysis	NN	I-NP
is	is	VBZ	0
a	a	DT	0
time-based	time-based	JJ	0
"snapshot	"snapshot	NN	0
"	"	''	0
of	of	IN	0
proteins	proteins	NNS	0
assumed	assumed	VBD	0
to	to	TO	0
be	be	VB	0
associated	associated	VBN	0
with	with	IN	0
physiologic	physiologic	JJ	B-NP
function	function	NN	I-NP
at	at	IN	0
the	the	DT	0
moment	moment	NN	0
of	of	IN	0
SMG	SMG	NNP	B-NP
harvesting	harvesting	NN	I-NP
.	.	.	0
Viewing	Viewing	VBG	0
the	the	DT	0
most	most	RBS	0
defining	defining	JJ	0
proteins	proteins	NNS	0
with	with	IN	0
altered	altered	JJ	0
expression	expression	NN	0
,	,	,	0
it	it	PRP	0
is	is	VBZ	0
clearly	clearly	RB	0
reflective	reflective	VBN	0
of	of	IN	0
increased	increased	JJ	0
apoptosi	apoptosi	NN	B-NP
(	(	-LRB-	0
increased	increased	VBN	B-NP
Chk1	Chk1	NNP	I-NP
,	,	,	0
Caspase	Caspase	NNP	B-NP
6	6	CD	0
,	,	,	0
E2F1	E2F1	CD	0
)	)	-RRB-	0
,	,	,	0
decreased	decreased	VBD	B-NP
cell	cell	NN	I-NP
proliferation	proliferation	NN	I-NP
and	and	CC	0
branching	branching	NNS	0
(	(	-LRB-	0
decreased	decreased	UH	B-NP
GR	GR	UH	I-NP
)	)	-RRB-	0
,	,	,	0
and	and	CC	0
,	,	,	0
interestingly	interestingly	RB	0
,	,	,	0
diverse	diverse	JJ	B-NP
signal	signal	NN	I-NP
transduction	transduction	NN	I-NP
pathway	pathway	NN	I-NP
increased	increased	VBN	I-NP
expression	expression	NN	I-NP
(	(	-LRB-	0
Ras	Ras	NNP	B-NP
/	/	NNP	I-NP
Raf	Raf	NNP	I-NP
/	/	NNP	I-NP
ERK	ERK	NNP	I-NP
,	,	,	0
jun	jun	NNP	B-NP
n	n	NN	I-NP
terminal	terminal	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
kinase	kinase	NN	I-NP
)	)	-RRB-	0
to	to	TO	0
compensate	compensate	VB	0
for	for	IN	0
the	the	DT	0
proapoptotic	proapoptotic	JJ	B-NP
signal	signal	NN	I-NP
.	.	.	0
Analysis	Analysis	NN	0
of	of	IN	0
activated	activated	JJ	0
pathway	pathway	JJ	B-NP
component	component	JJ	I-NP
We	We	PRP	0
then	then	RB	0
focused	focused	VBN	0
our	our	PRP$	0
attention	attention	NN	0
on	on	IN	0
two	two	CD	0
particularly	particularly	RB	0
important	important	JJ	0
pathways	pathways	JJ	0
relative	relative	JJ	0
to	to	TO	0
cell	cell	NN	0
proliferation	proliferation	NN	0
and	and	CC	0
apoptosi	apoptosi	NN	B-NP
,	,	,	0
extracellular	extracellular	NN	B-NP
signal	signal	JJ	I-NP
regulated	regulated	VBN	I-NP
kinase	kinase	NN	I-NP
1	1	CD	0
/	/	CD	0
2	2	CD	0
and	and	CC	0
Caspase	Caspase	NNP	B-NP
3	3	CD	0
.	.	.	0
Downstream	Downstream	NNP	0
of	of	IN	0
activated	activated	JJ	0
extracellular	extracellular	NN	B-NP
signal	signal	JJ	I-NP
regulated	regulated	VBN	I-NP
kinase	kinase	NN	I-NP
1	1	CD	0
/	/	CD	0
2	2	CD	0
is	is	VBZ	0
an	an	DT	0
upregulation	upregulation	NN	B-NP
of	of	IN	0
cell	cell	NN	0
proliferation	proliferation	NN	0
proteins	proteins	NNS	0
and	and	CC	0
potentially	potentially	RB	0
enhanced	enhanced	JJ	0
cell	cell	NN	0
division	division	NN	0
,	,	,	0
as	as	RB	0
well	well	RB	0
as	as	IN	0
a	a	DT	0
protective	protective	JJ	B-NP
effect	effect	NN	I-NP
over	over	IN	0
apoptotic	apoptotic	JJ	B-NP
signaling	signaling	NN	I-NP
via	via	IN	0
suppressed	suppressed	JJ	0
caspase	caspase	JJ	B-NP
effector	effector	NN	I-NP
activation	activation	NN	I-NP
.	.	.	0
Downstream	Downstream	NNP	0
of	of	IN	0
activated	activated	JJ	0
Caspase	Caspase	NNP	B-NP
3	3	CD	0
are	are	VBP	0
the	the	DT	0
apoptosi	apoptosi	NN	B-NP
sequellae	sequellae	NN	I-NP
,	,	,	0
including	including	VBG	B-NP
PARP	PARP	NNP	I-NP
cleavage	cleavage	NN	I-NP
and	and	CC	0
inhibition	inhibition	NN	0
of	of	IN	0
DNA	DNA	NNP	B-NP
repair	repair	NN	I-NP
,	,	,	0
DNA	DNA	NNP	B-NP
fragmentation	fragmentation	NN	I-NP
,	,	,	0
and	and	CC	0
nuclear	nuclear	JJ	0
membrane	membrane	JJ	B-NP
fragmentation	fragmentation	NN	I-NP
.	.	.	0
The	The	DT	0
increase	increase	NN	0
or	or	CC	0
decrease	decrease	NN	0
in	in	IN	0
expression	expression	NN	0
of	of	IN	0
the	the	DT	0
components	components	NNS	0
of	of	IN	0
any	any	DT	0
signaling	signaling	JJ	0
pathway	pathway	NN	0
is	is	VBZ	0
not	not	RB	0
necessarily	necessarily	RB	0
probative	probative	VBN	0
of	of	IN	0
pathway	pathway	JJ	B-NP
activity	activity	NN	I-NP
.	.	.	0
Rather	Rather	RB	0
,	,	,	0
it	it	PRP	0
is	is	VBZ	0
the	the	DT	0
change	change	NN	0
in	in	IN	0
the	the	DT	0
level	level	NN	0
of	of	IN	0
activated	activated	JJ	0
protein	protein	NN	B-NP
that	that	WDT	0
is	is	VBZ	0
physiologically	physiologically	JJ	B-NP
important	important	JJ	I-NP
.	.	.	0
Thus	Thus	RB	0
,	,	,	0
we	we	PRP	0
determined	determined	VBD	0
if	if	IN	0
SN50	SN50	CD	B-NP
treatment	treatment	NN	I-NP
was	was	VBD	0
associated	associated	VBN	0
with	with	IN	0
erk1	erk1	NN	B-NP
activation	activation	NN	I-NP
/	/	CD	0
2	2	CD	0
and	and	CC	0
Caspase	Caspase	NNP	B-NP
3	3	CD	0
pathways	pathways	NN	0
,	,	,	0
using	using	VBG	0
E15	E15	CD	B-NP
+	+	CD	0
2	2	CD	0
control	control	NN	0
and	and	CC	0
sn50-treated	sn50-treated	NN	B-NP
explant	explant	NN	I-NP
,	,	,	0
1-D	1-D	NNP	B-NP
Western	Western	NNP	I-NP
blot	blot	JJ	I-NP
analysis	analysis	NN	I-NP
,	,	,	0
and	and	CC	0
antibody	antibody	NN	B-NP
specific	specific	JJ	0
to	to	TO	0
activated	activated	VB	0
(	(	-LRB-	0
phosphorylated	phosphorylated	FW	0
/	/	FW	0
cleaved	cleaved	FW	0
)	)	-RRB-	0
proteins	proteins	NNS	0
.	.	.	0
Specifically	Specifically	RB	0
,	,	,	0
we	we	PRP	0
evaluated	evaluated	VBD	0
the	the	DT	0
levels	levels	NNS	0
of	of	IN	0
activated	activated	JJ	0
c-Raf	c-Raf	NN	B-NP
,	,	,	0
ERK1	ERK1	CD	B-NP
/	/	CD	0
2	2	CD	0
,	,	,	0
Caspase	Caspase	NNP	B-NP
3	3	CD	0
,	,	,	0
and	and	CC	0
PARP	PARP	NNP	B-NP
using	using	VBG	0
antibody	antibody	NN	B-NP
which	which	WDT	0
identify	identify	VBP	0
only	only	RB	0
the	the	DT	0
phosphorylated	phosphorylated	NN	0
or	or	CC	0
cleaved	cleaved	JJ	0
proteins	proteins	NNS	0
and	and	CC	0
do	do	VBP	0
not	not	RB	0
cross	cross	VB	0
react	react	VBN	0
with	with	IN	0
the	the	DT	0
inactive	inactive	JJ	B-NP
protein	protein	NN	I-NP
.	.	.	0
We	We	PRP	0
found	found	VBD	0
a	a	DT	0
significant	significant	JJ	0
increase	increase	NN	0
(	(	-LRB-	0
p	p	CD	0
<	<	SYM	0
0.05	0.05	CD	0
)	)	-RRB-	0
in	in	IN	0
activated	activated	CD	B-NP
ERK1	ERK1	CD	I-NP
/	/	CD	0
2	2	CD	0
,	,	,	0
Caspase	Caspase	NNP	B-NP
3	3	CD	0
,	,	,	0
and	and	CC	0
PARP	PARP	NNP	B-NP
in	in	IN	0
sn50-treated	sn50-treated	NN	B-NP
explant	explant	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
14	14	CD	0
)	)	-RRB-	0
;	;	:	0
no	no	DT	0
change	change	NN	0
was	was	VBD	0
seen	seen	VBN	0
in	in	IN	0
activated	activated	JJ	0
c-raf	c-raf	NN	B-NP
level	level	JJ	I-NP
between	between	IN	0
control	control	NN	0
and	and	CC	0
sn50-treated	sn50-treated	NN	B-NP
explant	explant	NN	I-NP
.	.	.	0
The	The	DT	0
greater	greater	JJR	0
than	than	IN	0
2-fold	2-fold	CD	0
increase	increase	NN	0
in	in	IN	0
Caspase	Caspase	NNP	B-NP
3	3	CD	0
activation	activation	NN	B-NP
is	is	VBZ	0
associated	associated	VBN	0
with	with	IN	0
a	a	DT	0
1.8-fold	1.8-fold	JJ	0
increase	increase	NN	0
in	in	IN	0
PARP	PARP	NNP	B-NP
cleavage	cleavage	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
14	14	CD	0
)	)	-RRB-	0
and	and	CC	0
a	a	DT	0
10-fold	10-fold	JJ	0
increase	increase	NN	0
in	in	IN	0
apoptosi	apoptosi	NN	B-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
4B	4B	NNP	0
)	)	-RRB-	0
.	.	.	0
Since	Since	IN	0
Caspase	Caspase	NNP	B-NP
3	3	CD	0
is	is	VBZ	0
nodal	nodal	VBN	B-NP
to	to	TO	0
E2F1	E2F1	CD	0
(	(	-LRB-	0
via	via	IN	0
p53	p53	NN	B-NP
)	)	-RRB-	0
,	,	,	0
FAF	FAF	NNP	B-NP
(	(	-LRB-	0
via	via	IN	0
Fas	Fas	NNP	B-NP
/	/	NNP	I-NP
Caspase	Caspase	NNP	I-NP
8	8	CD	0
)	)	-RRB-	0
,	,	,	0
and	and	CC	0
Caspase	Caspase	NNP	B-NP
6	6	CD	0
[	[	-LRB-	0
33	33	CD	0
36	36	CD	0
37	37	CD	0
39	39	CD	0
]	]	-RRB-	0
,	,	,	0
our	our	PRP$	0
observation	observation	NN	0
of	of	IN	0
increased	increased	VBN	0
activated	activated	VBN	B-NP
Caspase	Caspase	NNP	I-NP
3	3	CD	0
is	is	VBZ	0
consistent	consistent	JJ	0
with	with	IN	0
the	the	DT	0
increased	increased	JJ	0
levels	levels	NNS	0
of	of	IN	0
E2F1	E2F1	NNP	0
,	,	,	0
FAF	FAF	NNP	B-NP
,	,	,	0
and	and	CC	0
Caspase	Caspase	NNP	B-NP
6	6	CD	0
proteins	proteins	NNS	0
(	(	-LRB-	0
Table	Table	NNP	0
2	2	CD	0
)	)	-RRB-	0
.	.	.	0
Regarding	Regarding	VBG	0
the	the	DT	0
ERK1	ERK1	CD	B-NP
/	/	CD	0
2	2	CD	0
pathway	pathway	NN	0
,	,	,	0
we	we	PRP	0
found	found	VBD	0
a	a	DT	0
greater	greater	JJR	0
than	than	IN	0
2-fold	2-fold	CD	0
increase	increase	NN	0
of	of	IN	0
activated	activated	VBN	B-NP
ERK2	ERK2	NN	I-NP
in	in	FW	0
sn50-treated	sn50-treated	NN	B-NP
gland	gland	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
13	13	CD	0
)	)	-RRB-	0
associated	associated	VBN	0
with	with	IN	0
a	a	DT	0
1.5-fold	1.5-fold	JJ	0
increase	increase	NN	0
in	in	IN	0
total	total	JJ	B-NP
ERK2	ERK2	CD	I-NP
protein	protein	NN	I-NP
(	(	-LRB-	0
Table	Table	NNP	0
2	2	CD	0
)	)	-RRB-	0
.	.	.	0
This	This	DT	0
increased	increased	JJ	0
activity	activity	NN	0
of	of	IN	0
proapoptotic	proapoptotic	NN	B-NP
(	(	-LRB-	0
caspase3	caspase3	NNP	B-NP
/	/	NNP	0
PARP	PARP	NNP	B-NP
)	)	-RRB-	0
and	and	CC	0
compensatory	compensatory	JJ	B-NP
antiapoptotic	antiapoptotic	NN	I-NP
(	(	-LRB-	0
ERK1	ERK1	CD	B-NP
/	/	CD	0
2	2	CD	0
)	)	-RRB-	0
pathways	pathways	NN	0
is	is	VBZ	0
consistent	consistent	JJ	0
with	with	IN	0
the	the	DT	0
dramatic	dramatic	JJ	0
cell	cell	NN	0
death	death	NN	0
seen	seen	VBN	0
in	in	IN	0
sn50-treated	sn50-treated	NN	B-NP
smg	smg	NN	I-NP
.	.	.	0
Paradoxically	Paradoxically	NNP	0
,	,	,	0
increased	increased	VBD	B-NP
ERK1	ERK1	CD	I-NP
activation	activation	NN	I-NP
is	is	VBZ	0
seen	seen	VBN	0
despite	despite	IN	0
a	a	DT	0
1.6-fold	1.6-fold	JJ	0
decrease	decrease	NN	0
in	in	IN	0
total	total	JJ	B-NP
ERK1	ERK1	CD	I-NP
protein	protein	NN	I-NP
(	(	-LRB-	0
Table	Table	NNP	0
2	2	CD	0
)	)	-RRB-	0
and	and	CC	0
increased	increased	VBD	B-NP
ERK	ERK	NNP	I-NP
1	1	CD	0
/	/	CD	0
2	2	CD	0
activation	activation	NN	B-NP
is	is	VBZ	0
associated	associated	VBN	0
with	with	IN	0
virtually	virtually	RB	0
no	no	DT	0
change	change	NN	0
in	in	IN	0
the	the	DT	0
antecedent	antecedent	JJ	0
c-raf	c-raf	NN	B-NP
activation	activation	NN	I-NP
.	.	.	0
The	The	DT	0
latter	latter	NN	0
is	is	VBZ	0
consistent	consistent	JJ	0
with	with	IN	0
the	the	DT	0
demonstration	demonstration	NN	B-NP
that	that	IN	0
c-Raf	c-Raf	JJ	B-NP
function	function	NN	I-NP
is	is	VBZ	0
not	not	RB	0
mediated	mediated	VBN	0
by	by	IN	0
the	the	DT	0
MAPK	MAPK	NNP	B-NP
/	/	NNP	I-NP
ERK	ERK	NNP	I-NP
cascade	cascade	NN	I-NP
[	[	-LRB-	0
59	59	CD	0
]	]	-RRB-	0
.	.	.	0
Moreover	Moreover	RB	0
,	,	,	0
although	although	IN	0
we	we	PRP	0
find	find	VBP	0
an	an	DT	0
increase	increase	NN	0
in	in	IN	0
total	total	JJ	0
Raf	Raf	JJ	0
protein	protein	NN	0
(	(	-LRB-	0
Table	Table	NNP	0
2	2	CD	0
)	)	-RRB-	0
,	,	,	0
no	no	DT	0
increase	increase	NN	0
in	in	IN	0
activated	activated	JJ	0
c-Raf	c-Raf	NN	0
is	is	VBZ	0
found	found	VBN	0
;	;	:	0
we	we	PRP	0
also	also	RB	0
see	see	VB	0
a	a	DT	0
2-fold	2-fold	JJ	0
increase	increase	NN	0
in	in	IN	0
activated	activated	JJ	0
Caspase	Caspase	NNP	0
3	3	CD	0
but	but	CC	0
no	no	DT	0
change	change	NN	0
in	in	IN	0
total	total	JJ	0
Caspase	Caspase	NNP	0
3	3	CD	0
protein	protein	NN	0
.	.	.	0
These	These	DT	0
results	results	NNS	0
clearly	clearly	RB	0
illustrate	illustrate	VB	0
that	that	IN	0
changes	changes	NNS	0
in	in	IN	0
total	total	JJ	0
protein	protein	NN	0
level	level	NN	0
are	are	VBP	0
not	not	RB	0
always	always	RB	0
indicative	indicative	JJ	0
of	of	IN	0
altered	altered	JJ	0
protein	protein	NN	0
activity	activity	NN	0
.	.	.	0
Finally	Finally	RB	0
,	,	,	0
it	it	PRP	0
should	should	MD	0
be	be	VB	0
noted	noted	VBN	0
that	that	IN	0
a	a	DT	0
recent	recent	JJ	0
study	study	NN	0
using	using	VBG	0
cell	cell	NN	0
lines	lines	NNS	0
raised	raised	VBD	0
the	the	DT	0
possibility	possibility	NN	0
that	that	IN	0
SN50	SN50	NNP	0
's	's	POS	0
action	action	NN	0
is	is	VBZ	0
not	not	RB	0
specific	specific	JJ	0
to	to	TO	0
NF-κB	NF-κB	NNP	B-NP
[	[	-LRB-	0
61	61	CD	0
62	62	CD	0
]	]	-RRB-	0
.	.	.	0
SN50	SN50	NNP	B-NP
is	is	VBZ	0
composed	composed	VBN	0
of	of	IN	0
the	the	DT	0
nf-κb	nf-κb	NN	B-NP
p50	p50	NNP	I-NP
nuclear	nuclear	JJ	I-NP
localization	localization	NN	I-NP
signal	signal	NN	I-NP
and	and	CC	0
was	was	VBD	0
believed	believed	VBN	0
to	to	TO	0
specifically	specifically	RB	0
block	block	VB	0
NF-κB	NF-κB	JJ	B-NP
p50	p50	CD	I-NP
/	/	CD	0
p65	p65	CD	B-NP
nuclear	nuclear	JJ	0
translocation	translocation	NN	B-NP
by	by	IN	0
binding	binding	VBG	0
the	the	DT	0
receptor	receptor	NN	B-NP
complex	complex	NN	I-NP
nuclear	nuclear	JJ	I-NP
localization	localization	NN	I-NP
signal	signal	NN	I-NP
and	and	CC	0
preventing	preventing	VBG	B-NP
transport	transport	NN	I-NP
through	through	IN	0
the	the	DT	0
nuclear	nuclear	JJ	0
pore	pore	NNS	0
[	[	-LRB-	0
33	33	CD	0
34	34	CD	0
35	35	CD	0
]	]	-RRB-	0
.	.	.	0
However	However	RB	0
,	,	,	0
Torgerson	Torgerson	NNP	0
and	and	CC	0
coworker	coworker	NN	B-NP
[	[	-LRB-	0
61	61	CD	0
]	]	-RRB-	0
have	have	VBP	0
shown	shown	VBN	0
that	that	IN	0
SN50	SN50	CD	B-NP
treatment	treatment	NN	I-NP
inhibited	inhibited	VBD	0
nuclear	nuclear	JJ	0
transport	transport	NN	0
of	of	IN	0
nfat	nfat	NN	B-NP
transcription	transcription	JJ	I-NP
factor	factor	NN	I-NP
,	,	,	0
AP-1	AP-1	NNP	B-NP
,	,	,	0
STAT1	STAT1	NNP	B-NP
,	,	,	0
and	and	CC	0
NF-κB	NF-κB	JJ	B-NP
at	at	IN	0
a	a	DT	0
high	high	JJ	0
dose	dose	NN	0
of	of	IN	0
210	210	CD	0
μg	μg	CD	B-NP
/	/	CD	I-NP
ml	ml	NN	I-NP
in	in	IN	0
junkrat	junkrat	NN	B-NP
cell	cell	NN	I-NP
.	.	.	0
However	However	RB	0
,	,	,	0
others	others	NNS	0
have	have	VBP	0
shown	shown	VBN	0
that	that	IN	0
lower	lower	JJR	0
doses	doses	JJ	0
≤	≤	CD	0
100	100	CD	0
sn50	sn50	NN	B-NP
μg/ml	μg/ml	NN	I-NP
specifically	specifically	RB	0
inhibited	inhibited	VBD	B-NP
NF-κB	NF-κB	JJ	I-NP
nuclear	nuclear	JJ	0
translocation	translocation	NN	B-NP
in	in	IN	0
human	human	JJ	0
peripheral	peripheral	JJ	B-NP
blood	blood	NN	I-NP
lymphocyte	lymphocyte	NN	I-NP
and	and	CC	0
murine	murine	JJ	B-NP
t	t	NN	I-NP
cell	cell	NN	I-NP
[	[	-LRB-	0
33	33	CD	0
63	63	CD	0
]	]	-RRB-	0
.	.	.	0
These	These	DT	0
reported	reported	JJ	0
differences	differences	NNS	0
are	are	VBP	0
likely	likely	RB	0
due	due	JJ	0
to	to	TO	0
dose-dependent	dose-dependent	JJ	B-NP
or	or	CC	0
cell-specific	cell-specific	JJ	B-NP
difference	difference	NN	I-NP
in	in	IN	0
the	the	DT	0
effect	effect	NN	0
of	of	IN	0
SN50	SN50	NNP	B-NP
[	[	-LRB-	0
64	64	CD	0
]	]	-RRB-	0
.	.	.	0
Given	Given	VBN	0
that	that	IN	0
:	:	:	0
(	(	-LRB-	0
1	1	LS	0
)	)	-RRB-	0
embryonic	embryonic	JJ	B-NP
smg	smg	NN	I-NP
were	were	VBD	0
cultured	cultured	VBN	0
in	in	IN	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
100	100	CD	0
μg	μg	CD	B-NP
/	/	CD	I-NP
ml	ml	CD	I-NP
SN50	SN50	CD	I-NP
,	,	,	0
(	(	-LRB-	0
2	2	LS	0
)	)	-RRB-	0
immunodetectable	immunodetectable	JJ	B-NP
NF-κB	NF-κB	NN	I-NP
was	was	VBD	0
absent	absent	VBN	0
from	from	IN	0
smg	smg	NN	B-NP
epithelia	epithelia	NN	I-NP
nucleus	nucleus	NN	I-NP
in	in	FW	0
tumor	tumor	NN	B-NP
necrosi	necrosi	NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
factor	factor	NN	I-NP
+	+	FW	0
sn50-treated	sn50-treated	NN	B-NP
explant	explant	NN	I-NP
,	,	,	0
and	and	CC	0
(	(	-LRB-	0
3	3	LS	0
)	)	-RRB-	0
one	one	CD	0
cannot	cannot	CD	0
extrapolate	extrapolate	CD	0
observation	observation	NN	B-NP
in	in	IN	0
jurkat	jurkat	NN	B-NP
cell	cell	NN	I-NP
to	to	TO	0
those	those	DT	0
in	in	IN	0
primary	primary	JJ	B-NP
cell	cell	NN	I-NP
[	[	-LRB-	0
64	64	CD	0
]	]	-RRB-	0
or	or	CC	0
organ	organ	JJ	0
cultures	cultures	NNS	0
,	,	,	0
it	it	PRP	0
is	is	VBZ	0
most	most	RBS	0
probable	probable	JJ	0
that	that	IN	0
our	our	PRP$	0
observed	observed	JJ	0
smg	smg	NN	B-NP
development	development	NN	I-NP
interruption	interruption	NN	I-NP
is	is	VBZ	0
proximately	proximately	JJ	0
due	due	JJ	0
exclusively	exclusively	NN	0
to	to	TO	0
the	the	DT	0
inhibition	inhibition	NN	0
of	of	IN	0
NF-κB	NF-κB	JJ	B-NP
nuclear	nuclear	JJ	0
translocation	translocation	NN	B-NP
.	.	.	0
Indeed	Indeed	RB	0
,	,	,	0
for	for	IN	0
low	low	JJ	0
doses	doses	NNS	0
of	of	IN	0
SN50	SN50	NNP	B-NP
,	,	,	0
there	there	EX	0
is	is	VBZ	0
no	no	DT	0
evidence	evidence	NN	0
in	in	IN	0
the	the	DT	0
literature	literature	NN	0
to	to	TO	0
the	the	DT	0
contrary	contrary	NN	0
.	.	.	0
Nonetheless	Nonetheless	RB	0
,	,	,	0
we	we	PRP	0
do	do	VBP	0
recognize	recognize	VBN	0
that	that	IN	0
absence	absence	NN	B-NP
of	of	IN	0
evidence	evidence	NN	0
is	is	VBZ	0
not	not	RB	0
necessarily	necessarily	RB	0
evidence	evidence	NN	0
of	of	IN	0
absence	absence	NN	B-NP
.	.	.	0
Conclusions	Conclusions	VBG	0
Our	Our	PRP$	0
results	results	NNS	0
indicate	indicate	VBP	0
that	that	IN	0
NF-κB-mediated	NF-κB-mediated	JJ	B-NP
transcription	transcription	NN	I-NP
is	is	VBZ	0
directly	directly	RB	0
or	or	CC	0
indirectly	indirectly	RB	0
critical	critical	JJ	0
to	to	TO	0
embryonic	embryonic	JJ	B-NP
smg	smg	NN	I-NP
developmental	developmental	JJ	I-NP
homeostasi	homeostasi	NN	I-NP
.	.	.	0
We	We	PRP	0
demonstrate	demonstrate	VBP	0
the	the	DT	0
interplay	interplay	NN	0
between	between	IN	0
gene	gene	NN	B-NP
expression	expression	NN	I-NP
,	,	,	0
protein	protein	NN	B-NP
expression	expression	NN	I-NP
,	,	,	0
protein	protein	NN	0
activity	activity	NN	0
,	,	,	0
and	and	CC	0
morphology	morphology	NN	0
in	in	IN	0
response	response	NN	0
to	to	TO	0
NF-κB	NF-κB	JJ	B-NP
inhibition	inhibition	NN	I-NP
.	.	.	0
gene/protein	gene/protein	NN	B-NP
difference	difference	NN	I-NP
between	between	IN	0
control	control	NN	0
and	and	CC	0
nf-κb-inhibited	nf-κb-inhibited	NN	B-NP
phenotype	phenotype	NN	I-NP
are	are	VBP	0
not	not	RB	0
linearly	linearly	JJ	0
causal	causal	NN	0
of	of	IN	0
SMG	SMG	NNP	B-NP
dysplasia	dysplasia	NN	I-NP
.	.	.	0
In	In	IN	0
fact	fact	NN	0
,	,	,	0
these	these	DT	0
differences	differences	NNS	0
are	are	VBP	0
discovered	discovered	VBN	B-NP
correlation	correlation	NN	I-NP
between	between	IN	0
network	network	NN	B-NP
component	component	JJ	I-NP
and	and	CC	0
an	an	DT	0
emerging	emerging	VBG	B-NP
SMG	SMG	NNP	I-NP
phenotype	phenotype	NN	I-NP
,	,	,	0
a	a	DT	0
glimpse	glimpse	NN	0
of	of	IN	0
nonlinear	nonlinear	JJ	B-NP
organogenesi	organogenesi	NN	I-NP
[	[	-LRB-	0
65	65	CD	0
]	]	-RRB-	0
.	.	.	0
Considering	Considering	VBG	0
the	the	DT	0
outcome	outcome	NN	0
of	of	IN	0
this	this	DT	0
study	study	NN	0
relative	relative	JJ	0
to	to	TO	0
the	the	DT	0
Connections	Connections	NNP	B-NP
Map	Map	NNP	I-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
1	1	CD	0
)	)	-RRB-	0
,	,	,	0
it	it	PRP	0
is	is	VBZ	0
apparent	apparent	JJ	0
that	that	IN	0
NF-κB	NF-κB	JJ	B-NP
nuclear	nuclear	JJ	0
translocation	translocation	NN	B-NP
is	is	VBZ	0
functionally	functionally	JJ	0
integral	integral	NN	B-NP
to	to	TO	0
a	a	DT	0
genetic	genetic	JJ	B-NP
network	network	NN	I-NP
with	with	IN	0
broadly	broadly	RB	0
related	related	VBN	0
,	,	,	0
rather	rather	RB	0
than	than	IN	0
independent	independent	JJ	0
,	,	,	0
components	components	NNS	0
.	.	.	0
It	It	PRP	0
may	may	MD	0
be	be	VB	0
said	said	VBN	0
to	to	TO	0
represent	represent	VB	0
the	the	DT	0
collective	collective	JJ	B-NP
dynamic	dynamic	JJ	I-NP
of	of	IN	0
a	a	DT	0
"small-world	"small-world	NN	0
"	"	''	0
network	network	NN	0
such	such	JJ	0
that	that	IN	0
the	the	DT	0
average	average	JJ	0
number	number	NN	0
of	of	IN	0
factors	factors	NNS	0
in	in	IN	0
the	the	DT	0
shortest	shortest	JJS	0
chain	chain	NN	0
connecting	connecting	VBG	0
any	any	DT	0
two	two	CD	0
factors	factors	NNS	0
is	is	VBZ	0
small	small	JJ	0
[	[	-LRB-	0
66	66	CD	0
]	]	-RRB-	0
.	.	.	0
Such	Such	JJ	0
dynamical	dynamical	JJ	B-NP
system	system	NN	I-NP
with	with	IN	0
small-world	small-world	JJ	B-NP
couple	couple	NN	I-NP
display	display	VBP	0
enhanced	enhanced	VBN	B-NP
signal-propagation	signal-propagation	JJ	I-NP
speed	speed	NN	I-NP
and	and	CC	0
synchronizability	synchronizability	NN	B-NP
.	.	.	0
Thus	Thus	RB	0
,	,	,	0
if	if	IN	0
one	one	CD	0
focuses	focuses	NN	0
on	on	IN	0
the	the	DT	0
superimposition	superimposition	NN	B-NP
of	of	IN	0
the	the	DT	0
various	various	JJ	0
layers	layers	NNS	0
of	of	IN	0
information	information	NN	0
,	,	,	0
namely	namely	RB	0
morphology	morphology	JJ	0
,	,	,	0
gene	gene	NN	B-NP
expression	expression	NN	I-NP
,	,	,	0
protein	protein	NN	B-NP
expression	expression	NN	I-NP
,	,	,	0
and	and	CC	0
protein	protein	NN	0
activity	activity	NN	0
(	(	-LRB-	0
Figs.	Figs.	CD	0
3	3	CD	0
,	,	,	0
4	4	CD	0
,	,	,	0
5	5	CD	0
,	,	,	0
6	6	CD	0
,	,	,	0
7	7	CD	0
,	,	,	0
8	8	CD	0
,	,	,	0
9	9	CD	0
,	,	,	0
10	10	CD	0
,	,	,	0
11	11	CD	0
,	,	,	0
12	12	CD	0
,	,	,	0
13	13	CD	0
,	,	,	0
14	14	CD	0
)	)	-RRB-	0
,	,	,	0
one	one	PRP	0
can	can	MD	0
visualize	visualize	VB	0
a	a	DT	0
coordinated	coordinated	NN	0
,	,	,	0
multidimensional	multidimensional	JJ	B-NP
response	response	NN	I-NP
to	to	TO	0
inhibited	inhibited	VB	B-NP
NF-κB	NF-κB	JJ	I-NP
nuclear	nuclear	JJ	0
translocation	translocation	NN	B-NP
.	.	.	0
This	This	DT	0
visualization	visualization	NN	B-NP
,	,	,	0
however	however	RB	0
,	,	,	0
is	is	VBZ	0
necessarily	necessarily	RB	0
impressionistic	impressionistic	VBN	0
even	even	RB	0
though	though	IN	0
our	our	PRP$	0
assays	assays	NNS	0
have	have	VBP	0
some	some	DT	0
precision	precision	NN	0
.	.	.	0
This	This	DT	0
is	is	VBZ	0
so	so	RB	0
because	because	IN	0
we	we	PRP	0
cannot	cannot	VBP	0
extrapolate	extrapolate	VBN	0
from	from	IN	0
transcriptome	transcriptome	VBG	0
to	to	TO	0
proteome	proteome	VB	0
to	to	TO	0
activated	activated	VB	0
proteins	proteins	NNS	0
with	with	IN	0
any	any	DT	0
accuracy	accuracy	NN	B-NP
(	(	-LRB-	0
in	in	IN	0
the	the	DT	0
absence	absence	NN	B-NP
of	of	IN	0
actual	actual	JJ	0
steady-state	steady-state	JJ	B-NP
measure	measure	NN	I-NP
)	)	-RRB-	0
,	,	,	0
and	and	CC	0
because	because	RB	0
in	in	IN	0
these	these	DT	0
experiments	experiments	JJ	B-NP
time	time	NN	I-NP
is	is	VBZ	0
necessarily	necessarily	RB	0
cross-sectional	cross-sectional	JJ	0
,	,	,	0
not	not	RB	0
longitudinal	longitudinal	VBN	0
.	.	.	0
Nevertheless	Nevertheless	RB	0
,	,	,	0
relative	relative	JJ	0
to	to	TO	0
understanding	understanding	VB	0
a	a	DT	0
complex	complex	JJ	0
genetic	genetic	JJ	B-NP
network	network	NN	I-NP
and	and	CC	0
organogenesi	organogenesi	NN	B-NP
,	,	,	0
our	our	PRP$	0
results	results	NNS	0
demonstrate	demonstrate	VBP	0
the	the	DT	0
importance	importance	NN	0
of	of	IN	0
contemporaneously	contemporaneously	NNS	0
evaluating	evaluating	VBG	0
the	the	DT	0
gene	gene	NN	0
,	,	,	0
protein	protein	NN	B-NP
,	,	,	0
and	and	CC	0
activated	activated	JJ	0
protein	protein	NN	B-NP
expression	expression	NN	I-NP
of	of	IN	0
multiple	multiple	JJ	0
components	components	NNS	0
from	from	IN	0
multiple	multiple	JJ	0
pathways	pathways	NN	0
within	within	IN	0
broad	broad	JJ	0
functional	functional	JJ	B-NP
category	category	NN	I-NP
.	.	.	0
Understanding	Understanding	VBG	0
the	the	DT	0
signal	signal	NN	B-NP
dynamic	dynamic	JJ	I-NP
of	of	IN	0
these	these	DT	0
pathways	pathways	NN	0
will	will	MD	0
require	require	VB	0
expanded	expanded	VBN	B-NP
model	model	NN	I-NP
that	that	WDT	0
encompass	encompass	VBZ	0
more	more	JJR	0
aspects	aspects	NNS	0
of	of	IN	0
regulation	regulation	NN	0
[	[	-LRB-	0
e.g.	e.g.	NNP	0
[	[	-LRB-	0
67	67	CD	0
]	]	CD	0
]	]	-RRB-	0
.	.	.	0
Still	Still	RB	0
,	,	,	0
we	we	PRP	0
will	will	MD	0
always	always	RB	0
be	be	VB	0
limited	limited	VBN	0
by	by	IN	0
the	the	DT	0
fact	fact	NN	0
that	that	IN	0
phenotype	phenotype	NN	B-NP
are	are	VBP	0
complex	complex	JJ	0
,	,	,	0
emergent	emergent	JJ	0
phenomena	phenomena	NNS	0
[	[	-LRB-	0
16	16	CD	0
]	]	-RRB-	0
.	.	.	0
Materials	Materials	NNS	0
and	and	CC	0
Methods	Methods	NNP	0
Tissue	Tissue	NNP	0
collection	collection	NN	0
Female	Female	NNP	0
B10A	B10A	NNP	0
/	/	NNP	0
snsg	snsg	NN	B-NP
mouse	mouse	NN	I-NP
,	,	,	0
obtained	obtained	VBN	0
from	from	IN	0
Jackson	Jackson	NNP	0
Laboratories	Laboratories	NNPS	0
(	(	-LRB-	0
Bar	Bar	NNP	0
Harbor	Harbor	NNP	0
,	,	,	0
ME	ME	NNP	0
)	)	-RRB-	0
,	,	,	0
were	were	VBD	0
maintained	maintained	VBN	0
and	and	CC	0
mated	mated	VBN	0
as	as	IN	0
previously	previously	RB	0
described	described	VBN	0
[	[	-LRB-	0
60	60	CD	0
]	]	-RRB-	0
;	;	:	0
plug	plug	JJ	B-NP
day	day	NN	I-NP
=	=	SYM	0
day	day	NN	0
0	0	CD	0
of	of	IN	0
gestation	gestation	NN	B-NP
.	.	.	0
Pregnant	Pregnant	JJ	0
females	females	NNS	0
were	were	VBD	0
anesthetized	anesthetized	VBN	0
on	on	IN	0
days	days	NNS	0
15-19	15-19	VBP	0
of	of	IN	0
gestation	gestation	NN	B-NP
(	(	-LRB-	0
E15-18	E15-18	NNP	B-NP
)	)	-RRB-	0
with	with	IN	0
methoxyflurana	methoxyflurana	NN	B-NP
(	(	-LRB-	0
metafane	metafane	LS	B-NP
)	)	-RRB-	0
and	and	CC	0
euthanized	euthanized	NN	0
by	by	IN	0
cervical	cervical	JJ	B-NP
dislocation	dislocation	NN	I-NP
.	.	.	0
Embryos	Embryos	NNP	0
were	were	VBD	0
dissected	dissected	VBN	0
in	in	IN	0
cold	cold	JJ	0
phosphate	phosphate	NN	B-NP
buffered	buffered	FW	0
saline	saline	FW	0
(	(	-LRB-	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
)	)	-RRB-	0
and	and	CC	0
staged	staged	VBD	0
according	according	VBG	0
to	to	TO	0
Theiler	Theiler	NNP	0
[	[	-LRB-	0
68	68	CD	0
]	]	-RRB-	0
.	.	.	0
smg	smg	NN	B-NP
were	were	VBD	0
dissected	dissected	VBN	0
and	and	CC	0
cultured	cultured	NN	0
,	,	,	0
processed	processed	VBN	0
for	for	IN	0
histology	histology	NN	B-NP
,	,	,	0
or	or	CC	0
stored	stored	VBD	0
at	at	IN	0
-70°C	-70°C	CD	0
.	.	.	0
For	For	IN	0
cDNA	cDNA	JJ	B-NP
expression	expression	NN	I-NP
and	and	CC	0
proteomic	proteomic	JJ	B-NP
study	study	NN	I-NP
,	,	,	0
E15	E15	CD	B-NP
+	+	CD	0
2	2	CD	0
explant	explant	NN	B-NP
were	were	VBD	0
collected	collected	VBN	0
,	,	,	0
pooled	pooled	VBN	0
,	,	,	0
and	and	CC	0
stored	stored	VBD	0
at	at	IN	0
-70°C	-70°C	CD	0
.	.	.	0
Culture	Culture	NN	B-NP
system	system	NN	I-NP
E15	E15	NNP	I-NP
SMG	SMG	NNP	I-NP
(	(	-LRB-	0
mostly	mostly	RB	0
Canalicular	Canalicular	NNP	B-NP
Stage	Stage	NNP	I-NP
)	)	-RRB-	0
primordia	primordia	NN	B-NP
were	were	VBD	0
cultured	cultured	VBN	0
using	using	VBG	0
a	a	DT	0
modified	modified	JJ	0
Trowell	Trowell	JJ	B-NP
method	method	NN	I-NP
as	as	IN	0
previously	previously	RB	0
described	described	VBN	0
[	[	-LRB-	0
13	13	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
medium	medium	NN	0
consisted	consisted	VBD	0
of	of	IN	0
BGJb	BGJb	NNP	B-NP
(	(	-LRB-	0
Life	Life	NNP	0
Technologies	Technologies	NNPS	0
,	,	,	0
Rockville	Rockville	NNP	B-NP
,	,	,	0
MD	MD	NNP	0
)	)	-RRB-	0
supplemented	supplemented	NN	0
with	with	IN	0
0.5	0.5	CD	0
mg	mg	NN	B-NP
ascorbic	ascorbic	JJ	I-NP
acid	acid	JJ	I-NP
/	/	NN	I-NP
ml	ml	NN	I-NP
and	and	CC	0
50	50	CD	0
units	units	NNS	0
penicillin	penicillin	VBD	0
/	/	CD	0
streptomycin	streptomycin	NNS	0
(	(	-LRB-	0
Life	Life	NNP	0
Technologies	Technologies	NNPS	0
)	)	-RRB-	0
,	,	,	0
pH	pH	JJ	0
7.2	7.2	CD	0
,	,	,	0
and	and	CC	0
replicate	replicate	JJ	B-NP
culture	culture	NN	I-NP
were	were	VBD	0
changed	changed	VBN	0
every	every	DT	0
other	other	JJ	0
day	day	NN	0
.	.	.	0
Cultures	Cultures	NNS	0
were	were	VBD	0
supplemented	supplemented	VBN	0
on	on	IN	0
day	day	NN	0
0	0	CD	0
and	and	CC	0
maintained	maintained	VBN	0
for	for	IN	0
the	the	DT	0
duration	duration	NN	0
of	of	IN	0
the	the	DT	0
experiments	experiments	NNS	0
.	.	.	0
In	In	IN	0
each	each	DT	0
of	of	IN	0
the	the	DT	0
enumerated	enumerated	JJ	0
studies	studies	NNS	0
,	,	,	0
a	a	DT	0
minimum	minimum	NN	0
of	of	IN	0
12	12	CD	0
explant	explant	NN	B-NP
were	were	VBD	0
cultured	cultured	VBN	0
for	for	IN	0
2	2	CD	0
or	or	CC	0
4	4	CD	0
days	days	NNS	0
in	in	IN	0
the	the	DT	0
cell	cell	NN	0
permeable	permeable	FW	0
peptide	peptide	NN	B-NP
SN50	SN50	NN	I-NP
(	(	-LRB-	0
Biomol	Biomol	NNP	B-NP
Research	Research	NNP	I-NP
,	,	,	0
Plymouth	Plymouth	NNP	B-NP
Meeting	Meeting	NNP	I-NP
,	,	,	0
PA	PA	NNP	0
)	)	-RRB-	0
which	which	WDT	0
inhibits	inhibits	VBZ	0
NF-κB	NF-κB	JJ	B-NP
translocation	translocation	NN	I-NP
into	into	IN	0
the	the	DT	0
nucleus	nucleus	NN	B-NP
[	[	-LRB-	0
24	24	CD	0
33	33	CD	0
34	34	CD	0
35	35	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
concentration	concentration	NN	B-NP
used	used	VBN	0
(	(	-LRB-	0
100	100	CD	0
μg	μg	CD	B-NP
/	/	CD	I-NP
ml	ml	CD	I-NP
)	)	-RRB-	0
was	was	VBD	0
double	double	RB	0
that	that	IN	0
shown	shown	VBN	0
to	to	TO	0
inhibit	inhibit	VB	0
NF-κB	NF-κB	JJ	B-NP
translocation	translocation	NN	I-NP
in	in	IN	0
mouse	mouse	JJ	0
endothelial	endothelial	JJ	B-NP
le-ii	le-ii	NN	I-NP
cell	cell	NN	I-NP
;	;	:	0
100	100	CD	0
μg	μg	NN	B-NP
/	/	NN	I-NP
ml	ml	NN	I-NP
mutant	mutant	NN	I-NP
SN50	SN50	NN	I-NP
(	(	-LRB-	0
mSN50	mSN50	NNP	B-NP
)	)	-RRB-	0
peptide	peptide	NN	B-NP
was	was	VBD	0
used	used	VBN	0
as	as	IN	0
a	a	DT	0
positive	positive	JJ	B-NP
control	control	NN	I-NP
and	and	CC	0
control	control	VB	0
BGJb	BGJb	JJ	B-NP
medium	medium	NN	I-NP
as	as	IN	0
a	a	DT	0
negative	negative	JJ	B-NP
control	control	NN	I-NP
.	.	.	0
We	We	PRP	0
evaluated	evaluated	VBD	0
their	their	PRP$	0
microanatomy	microanatomy	NN	B-NP
by	by	IN	0
routine	routine	JJ	B-NP
hematoxylin	hematoxylin	NN	I-NP
and	and	CC	0
eosin	eosin	JJ	B-NP
histology	histology	NN	I-NP
.	.	.	0
We	We	PRP	0
report	report	VBP	0
a	a	DT	0
marked	marked	JJ	0
difference	difference	NN	0
between	between	IN	0
SN50-treated	SN50-treated	NNP	B-NP
and	and	CC	0
control	control	NN	B-NP
explant	explant	NN	I-NP
or	or	CC	0
sn50-and	sn50-and	NN	B-NP
msn50	msn50	NN	I-NP
peptide-treated	peptide-treated	JJ	I-NP
explant	explant	NN	I-NP
.	.	.	0
No	No	DT	0
differences	differences	NNS	0
were	were	VBD	0
observed	observed	VBN	0
between	between	IN	0
control	control	NN	0
and	and	CC	0
msn50-treated	msn50-treated	NN	B-NP
explant	explant	NN	I-NP
.	.	.	0
Since	Since	IN	0
these	these	DT	0
initial	initial	JJ	0
studies	studies	NNS	0
demonstrated	demonstrated	VBD	0
no	no	DT	0
difference	difference	NN	0
between	between	IN	0
explants	explants	JJ	B-NP
cultured	cultured	NN	I-NP
in	in	IN	0
control	control	NN	B-NP
medium	medium	JJ	I-NP
alone	alone	RB	0
and	and	CC	0
in	in	IN	0
mutant	mutant	JJ	B-NP
peptide	peptide	NN	I-NP
,	,	,	0
control	control	NN	B-NP
medium	medium	JJ	I-NP
was	was	VBD	0
used	used	VBN	0
as	as	IN	0
the	the	DT	0
control	control	NN	0
in	in	IN	0
all	all	DT	0
subsequent	subsequent	JJ	0
experiments	experiments	NNS	0
.	.	.	0
Ten	Ten	CD	0
independent	independent	JJ	0
experiments	experiments	NNS	0
of	of	IN	0
E15	E15	CD	B-NP
primordon	primordon	NN	I-NP
were	were	VBD	0
cultured	cultured	VBN	0
for	for	IN	0
2	2	CD	0
days	days	NNS	0
(	(	-LRB-	0
E15	E15	CD	B-NP
+	+	CD	0
2	2	CD	0
)	)	-RRB-	0
in	in	IN	0
CONT	CONT	NNP	B-NP
(	(	-LRB-	0
control	control	NN	0
)	)	-RRB-	0
or	or	CC	0
sn50-supplemented	sn50-supplemented	NN	B-NP
medium	medium	JJ	I-NP
,	,	,	0
each	each	DT	0
group	group	NN	0
consisting	consisting	VBG	0
of	of	IN	0
a	a	DT	0
minimum	minimum	NN	0
of	of	IN	0
8	8	CD	0
explant	explant	NN	B-NP
per	per	IN	0
group	group	NN	0
.	.	.	0
E15+2	E15+2	NNP	B-NP
explant	explant	NN	B-NP
were	were	VBD	0
collected	collected	VBN	0
and	and	CC	0
processed	processed	VBN	0
as	as	RB	0
described	described	VBN	0
below	below	RB	0
.	.	.	0
To	To	TO	0
further	further	RB	0
demonstrate	demonstrate	VB	0
that	that	IN	0
inhibited	inhibited	VBD	B-NP
nb-κb	nb-κb	NN	I-NP
activation	activation	NN	I-NP
sn50	sn50	NN	I-NP
treatment	treatment	NN	I-NP
,	,	,	0
we	we	PRP	0
evaluated	evaluated	VBD	0
if	if	IN	0
TNF	TNF	NNP	B-NP
supplementation	supplementation	NN	I-NP
would	would	MD	0
induce	induce	VB	0
NF-κB	NF-κB	JJ	B-NP
translocation	translocation	NN	I-NP
and	and	CC	0
smg	smg	NN	B-NP
morphogenesi	morphogenesi	NN	I-NP
.	.	.	0
e15	e15	NN	B-NP
smg	smg	NN	I-NP
were	were	VBD	0
cultured	cultured	VBN	0
for	for	IN	0
4	4	CD	0
days	days	NNS	0
or	or	CC	0
longer	longer	JJR	0
in	in	IN	0
10	10	CD	0
U	U	NNP	B-NP
/	/	NN	I-NP
ml	ml	NN	I-NP
recombinant	recombinant	FW	0
mouse	mouse	NN	B-NP
TNF	TNF	NN	I-NP
(	(	-LRB-	0
rTNF	rTNF	NNP	B-NP
,	,	,	0
R	R	NNP	0
&	&	CC	0
D	D	NNP	0
,	,	,	0
minneapoli	minneapoli	NN	B-NP
,	,	,	0
MN	MN	NNP	B-NP
)	)	-RRB-	0
,	,	,	0
100	100	CD	0
μg	μg	CD	B-NP
/	/	CD	I-NP
ml	ml	CD	I-NP
SN50	SN50	CD	I-NP
+	+	CD	0
10	10	CD	0
U	U	NNP	B-NP
/	/	NNP	I-NP
ml	ml	VBD	I-NP
rTNF	rTNF	JJ	I-NP
,	,	,	0
or	or	CC	0
100	100	CD	0
μg	μg	CD	B-NP
/	/	CD	I-NP
ml	ml	CD	I-NP
mSN50	mSN50	CD	I-NP
+	+	CD	0
10	10	CD	0
U	U	NNP	B-NP
/	/	NNP	I-NP
ml	ml	VBD	I-NP
rTNF	rTNF	JJ	I-NP
,	,	,	0
6-10	6-10	FW	0
explant	explant	NN	B-NP
per	per	FW	0
treatment	treatment	NN	B-NP
group	group	NN	I-NP
.	.	.	0
This	This	DT	0
rTNF	rTNF	JJ	B-NP
concentration	concentration	NN	I-NP
was	was	VBD	0
previously	previously	RB	0
shown	shown	VBN	0
in	in	IN	0
our	our	PRP$	0
laboratory	laboratory	NN	0
to	to	TO	0
induce	induce	VB	0
embryonic	embryonic	JJ	B-NP
smg	smg	NN	I-NP
morphogenesi	morphogenesi	NN	I-NP
and	and	CC	0
cell	cell	NN	0
proliferation	proliferation	NN	0
[	[	-LRB-	0
13	13	CD	0
]	]	-RRB-	0
.	.	.	0
explant	explant	NN	B-NP
were	were	VBD	0
collected	collected	VBN	0
and	and	CC	0
evaluated	evaluated	VBN	0
by	by	IN	0
histological	histological	NN	B-NP
and	and	CC	0
immunochemical	immunochemical	JJ	B-NP
analysis	analysis	NN	I-NP
as	as	RB	0
described	described	VBN	0
below	below	RB	0
.	.	.	0
Histology	Histology	NNP	B-NP
and	and	CC	0
immunolocalization	immunolocalization	JJ	B-NP
smg	smg	NN	I-NP
were	were	VBD	0
fixed	fixed	VBN	B-NP
in	in	IN	0
Carnoy	Carnoy	NNP	0
's	's	POS	0
fixative	fixative	NN	B-NP
,	,	,	0
processed	processed	VBN	0
,	,	,	0
embedded	embedded	VBN	0
in	in	IN	0
low-melting	low-melting	JJ	0
point	point	NN	B-NP
paraplast	paraplast	NN	I-NP
,	,	,	0
and	and	CC	0
stored	stored	VBD	0
for	for	IN	0
brief	brief	JJ	0
periods	periods	NNS	0
at	at	IN	0
4°C	4°C	CD	0
as	as	IN	0
previously	previously	RB	0
described	described	VBN	0
[	[	-LRB-	0
13	13	CD	0
]	]	-RRB-	0
.	.	.	0
cultured	cultured	JJ	B-NP
explant	explant	JJ	I-NP
morphogenesi	morphogenesi	NN	I-NP
was	was	VBD	0
analyzed	analyzed	VBN	0
by	by	IN	0
dissecting	dissecting	JJ	0
microscopy	microscopy	NN	0
and	and	CC	0
by	by	IN	0
light	light	JJ	0
microscopy	microscopy	NN	0
of	of	IN	0
serial	serial	JJ	0
sections	sections	NNS	0
stained	stained	VBN	0
with	with	IN	0
hematoxylin	hematoxylin	NN	B-NP
and	and	CC	0
eosin	eosin	NN	B-NP
.	.	.	0
A	A	DT	0
minimum	minimum	NN	0
of	of	IN	0
5	5	CD	0
explant	explant	NN	B-NP
per	per	IN	0
group	group	NN	0
was	was	VBD	0
evaluated	evaluated	VBN	0
for	for	IN	0
all	all	DT	0
experimental	experimental	JJ	B-NP
group	group	NN	I-NP
.	.	.	0
For	For	IN	0
immunochemistry	immunochemistry	NN	B-NP
,	,	,	0
the	the	DT	0
tissues	tissues	NNS	0
were	were	VBD	0
sectioned	sectioned	VBN	0
at	at	IN	0
7	7	CD	0
μm	μm	NN	B-NP
,	,	,	0
placed	placed	VBN	0
on	on	IN	0
cleaned	cleaned	NN	0
,	,	,	0
gelatin-coated	gelatin-coated	JJ	0
slides	slides	NNS	0
at	at	IN	0
37°C	37°C	CD	0
for	for	IN	0
3	3	CD	0
hr	hr	NN	B-NP
,	,	,	0
and	and	CC	0
immediately	immediately	RB	0
immunostained	immunostained	VBN	0
as	as	IN	0
previously	previously	RB	0
described	described	VBN	0
[	[	-LRB-	0
9	9	CD	0
13	13	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
sections	sections	NNS	0
were	were	VBD	0
incubated	incubated	VBN	0
in	in	IN	0
polyclonal	polyclonal	NN	B-NP
goat	goat	NN	I-NP
anti-NF-κB	anti-NF-κB	NN	I-NP
p65	p65	NN	I-NP
/	/	FW	0
RelA	RelA	NN	B-NP
antibody	antibody	NN	I-NP
(	(	-LRB-	0
C-20	C-20	NNP	B-NP
)	)	-RRB-	0
(	(	-LRB-	0
Santa	Santa	NNP	0
Cruz	Cruz	NNP	0
Biotechnology	Biotechnology	NNP	0
,	,	,	0
Santa	Santa	NNP	0
Cruz	Cruz	NNP	0
,	,	,	0
cyproterone	cyproterone	NN	B-NP
acetate	acetate	NN	I-NP
)	)	-RRB-	0
;	;	:	0
this	this	DT	0
antibody	antibody	NN	B-NP
has	has	VBZ	0
been	been	VBN	0
shown	shown	VBN	0
to	to	TO	0
cross-react	cross-react	JJ	0
with	with	IN	0
mouse	mouse	CD	B-NP
p65	p65	CD	I-NP
;	;	:	0
it	it	PRP	0
is	is	VBZ	0
not	not	RB	0
cross-reactive	cross-reactive	JJ	B-NP
with	with	IN	0
RelB	RelB	NNP	B-NP
p68	p68	NNP	I-NP
or	or	CC	0
c-Rel	c-Rel	JJ	B-NP
p75	p75	NN	I-NP
.	.	.	0
We	We	PRP	0
confirmed	confirmed	VBD	0
the	the	DT	0
nf-κb	nf-κb	NN	B-NP
spatial	spatial	JJ	I-NP
distribution	distribution	NN	I-NP
using	using	VBG	0
a	a	DT	0
polyclonal	polyclonal	NN	B-NP
goat	goat	NN	I-NP
anti-NF-κB	anti-NF-κB	NN	I-NP
p50	p50	NN	I-NP
antibody	antibody	NN	I-NP
(	(	-LRB-	0
C-19	C-19	NNP	B-NP
)	)	-RRB-	0
(	(	-LRB-	0
Santa	Santa	NNP	0
Cruz	Cruz	NNP	0
Biotechnology	Biotechnology	NNP	0
)	)	-RRB-	0
;	;	:	0
this	this	DT	0
antibody	antibody	NN	B-NP
has	has	VBZ	0
been	been	VBN	0
shown	shown	VBN	0
to	to	TO	0
react	react	VB	0
with	with	IN	0
mouse	mouse	NN	B-NP
p50	p50	NN	I-NP
or	or	CC	0
p105	p105	NNP	B-NP
;	;	:	0
it	it	PRP	0
is	is	VBZ	0
not	not	RB	0
cross-reactive	cross-reactive	JJ	B-NP
with	with	IN	0
NF-κB	NF-κB	NNP	B-NP
p52	p52	NNP	I-NP
,	,	,	0
p65	p65	NNP	B-NP
/	/	NNP	0
RelA	RelA	NNP	B-NP
or	or	CC	0
p100	p100	NNP	B-NP
.	.	.	0
Controls	Controls	NNS	0
consisted	consisted	VBD	0
of	of	IN	0
sections	sections	JJ	0
incubated	incubated	NN	0
with	with	IN	0
preimmune	preimmune	JJ	B-NP
serum	serum	NN	I-NP
or	or	CC	0
in	in	IN	0
the	the	DT	0
primary	primary	JJ	B-NP
antibody	antibody	NN	I-NP
absence	absence	NN	I-NP
;	;	:	0
controls	controls	NNS	0
were	were	VBD	0
routinely	routinely	RB	0
negative	negative	JJ	0
.	.	.	0
The	The	DT	0
nf-κb	nf-κb	NN	B-NP
p65	p65	NNP	I-NP
spatial	spatial	JJ	I-NP
distribution	distribution	NN	I-NP
was	was	VBD	0
identical	identical	JJ	0
to	to	TO	0
that	that	DT	0
of	of	IN	0
NF-κB	NF-κB	JJ	B-NP
p50	p50	NN	I-NP
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
we	we	PRP	0
only	only	RB	0
show	show	VB	0
the	the	DT	0
results	results	NNS	0
of	of	IN	0
the	the	DT	0
anti-nf-κb	anti-nf-κb	NN	B-NP
p65	p65	CD	I-NP
antibody	antibody	NN	I-NP
experiment	experiment	NN	I-NP
.	.	.	0
Quantitation	Quantitation	NNP	B-NP
of	of	IN	0
activated	activated	JJ	0
p53	p53	NN	B-NP
To	To	TO	0
quantitate	quantitate	VB	0
differences	differences	NNS	0
in	in	IN	0
activated	activated	NNS	0
(	(	-LRB-	0
phosphorylated	phosphorylated	LS	0
)	)	-RRB-	0
p53	p53	NN	B-NP
protein	protein	NN	I-NP
,	,	,	0
3	3	CD	0
SN50	SN50	CD	B-NP
and	and	CC	0
control	control	NN	B-NP
E15	E15	CD	I-NP
+	+	CD	0
2	2	CD	0
explant	explant	NN	B-NP
were	were	VBD	0
sectioned	sectioned	CD	0
,	,	,	0
preincubated	preincubated	VBG	0
with	with	IN	0
unlabeled	unlabeled	JJ	0
goat-anti	goat-anti	JJ	B-NP
mouse	mouse	NN	I-NP
IgG	IgG	NN	I-NP
as	as	IN	0
previously	previously	RB	0
described	described	VBN	0
[	[	-LRB-	0
9	9	CD	0
]	]	-RRB-	0
and	and	CC	0
sequentially	sequentially	JJ	0
incubated	incubated	NN	0
with	with	IN	0
a	a	DT	0
monoclonal	monoclonal	JJ	B-NP
anti-phosphorylated	anti-phosphorylated	JJ	I-NP
p53	p53	NN	I-NP
(	(	-LRB-	0
Ser15	Ser15	NNP	B-NP
)	)	-RRB-	0
antibody	antibody	NN	B-NP
(	(	-LRB-	0
Cell	Cell	NNP	0
Signaling	Signaling	NNP	B-NP
Technology	Technology	NNP	I-NP
,	,	,	0
Beverly	Beverly	NNP	0
,	,	,	0
MA	MA	NNP	0
)	)	-RRB-	0
,	,	,	0
biotin-labeled	biotin-labeled	JJ	B-NP
goat	goat	JJ	I-NP
anti-mouse	anti-mouse	JJ	I-NP
IgG	IgG	NN	I-NP
,	,	,	0
and	and	CC	0
HRP-labeled	HRP-labeled	NNP	B-NP
SA	SA	NNP	0
(	(	-LRB-	0
Zymed	Zymed	NNP	0
Laboratories	Laboratories	NNPS	0
,	,	,	0
South	South	NNP	0
San	San	NNP	0
Francisco	Francisco	NNP	0
,	,	,	0
cyproterone	cyproterone	NN	B-NP
acetate	acetate	NN	I-NP
)	)	-RRB-	0
,	,	,	0
and	and	CC	0
counterstained	counterstained	NN	0
with	with	IN	0
hematoxylin	hematoxylin	NN	B-NP
.	.	.	0
Controls	Controls	NNS	0
consisted	consisted	VBD	0
of	of	IN	0
preimmune	preimmune	JJ	B-NP
serum	serum	NN	I-NP
or	or	CC	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
alone	alone	RB	0
.	.	.	0
In	In	IN	0
this	this	DT	0
set	set	NN	0
of	of	IN	0
experiments	experiments	NNS	0
,	,	,	0
the	the	DT	0
cytoplasm	cytoplasm	NN	B-NP
appears	appears	VBZ	0
blue	blue	JJ	0
and	and	CC	0
activated	activated	CD	B-NP
p53-positive	p53-positive	CD	I-NP
cell	cell	NN	I-NP
appear	appear	VBP	0
dark	dark	JJ	0
brown	brown	NN	0
.	.	.	0
Three	Three	CD	0
sections	sections	NNS	0
per	per	IN	0
group	group	NN	0
were	were	VBD	0
selected	selected	VBN	0
and	and	CC	0
3	3	CD	0
areas	areas	NNS	0
per	per	IN	0
section	section	NN	0
was	was	VBD	0
photographed	photographed	VBN	0
at	at	IN	0
200×.	200×.	CD	0
p53-positive	p53-positive	CD	B-NP
epithelial	epithelial	JJ	I-NP
cells/total	cells/total	NN	I-NP
epithelial	epithelial	JJ	I-NP
cell	cell	NN	I-NP
were	were	VBD	0
determined	determined	VBN	0
per	per	IN	0
area	area	NN	0
and	and	CC	0
the	the	DT	0
mean	mean	JJ	0
ratios	ratios	NNS	0
per	per	IN	0
section	section	NN	0
and	and	CC	0
per	per	IN	0
group	group	NN	0
were	were	VBD	0
determined	determined	VBN	0
.	.	.	0
statistical	statistical	JJ	B-NP
comparison	comparison	NN	I-NP
were	were	VBD	0
made	made	VBN	0
between	between	IN	0
CONT	CONT	NNP	B-NP
and	and	CC	0
SN50-treated	SN50-treated	CD	B-NP
E15	E15	CD	I-NP
+	+	CD	0
2	2	CD	0
explant	explant	NN	B-NP
as	as	RB	0
described	described	VBN	0
below	below	RB	0
.	.	.	0
Cell	Cell	NN	0
proliferation	proliferation	NN	0
assay	assay	VBD	0
E15	E15	CD	B-NP
+	+	CD	0
2	2	CD	0
CONT	CONT	NNP	B-NP
or	or	CC	0
sn50-treated	sn50-treated	NN	B-NP
explant	explant	NN	I-NP
were	were	VBD	0
sectioned	sectioned	CD	0
,	,	,	0
incubated	incubated	VBG	0
with	with	IN	0
anti-PCNA	anti-PCNA	JJ	B-NP
using	using	VBG	0
the	the	DT	0
Zymed	Zymed	NNP	B-NP
mouse	mouse	NN	I-NP
PCNA	PCNA	NN	I-NP
kit	kit	NN	I-NP
(	(	-LRB-	0
South	South	NNP	0
San	San	NNP	0
Francisco	Francisco	NNP	0
,	,	,	0
cyproterone	cyproterone	NN	B-NP
acetate	acetate	NN	I-NP
)	)	-RRB-	0
,	,	,	0
and	and	CC	0
counterstained	counterstained	NN	0
with	with	IN	0
hematoxylin	hematoxylin	NN	B-NP
as	as	IN	0
previously	previously	RB	0
described	described	VBN	0
[	[	-LRB-	0
13	13	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
this	this	DT	0
set	set	NN	0
of	of	IN	0
experiments	experiments	NNS	0
,	,	,	0
the	the	DT	0
cytoplasm	cytoplasm	NN	B-NP
appears	appears	VBZ	0
blue	blue	JJ	0
and	and	CC	0
pcna-positive	pcna-positive	NN	B-NP
cell	cell	NN	I-NP
appear	appear	VBP	0
dark	dark	JJ	0
brown	brown	NN	0
.	.	.	0
Quantitation	Quantitation	NNP	B-NP
of	of	IN	0
cell	cell	NN	0
proliferation	proliferation	NN	0
was	was	VBD	0
conducted	conducted	VBN	0
as	as	RB	0
described	described	VBN	0
above	above	IN	0
for	for	IN	0
p53	p53	NN	B-NP
.	.	.	0
Cell	Cell	NN	0
proliferation	proliferation	NN	0
is	is	VBZ	0
presented	presented	VBN	0
as	as	IN	0
the	the	DT	0
ratio	ratio	NN	0
of	of	IN	0
pcna-positive	pcna-positive	NN	B-NP
epithelial	epithelial	JJ	I-NP
cells/total	cells/total	NN	I-NP
epithelial	epithelial	JJ	I-NP
cell	cell	NN	I-NP
.	.	.	0
mean	mean	JJ	B-NP
ratio	ratio	NN	I-NP
per	per	IN	0
section	section	NN	0
and	and	CC	0
mean	mean	VB	0
ratios	ratios	NNS	0
per	per	IN	0
group	group	NN	0
were	were	VBD	0
determined	determined	VBN	0
.	.	.	0
statistical	statistical	JJ	B-NP
comparison	comparison	NN	I-NP
were	were	VBD	0
made	made	VBN	0
between	between	IN	0
CONT	CONT	NNP	B-NP
and	and	CC	0
SN50-treated	SN50-treated	CD	B-NP
E15	E15	CD	I-NP
+	+	CD	0
2	2	CD	0
explant	explant	NN	B-NP
as	as	RB	0
described	described	VBN	0
below	below	RB	0
.	.	.	0
apoptotic	apoptotic	NN	B-NP
cell	cell	NN	I-NP
apoptosi	apoptosi	NN	I-NP
assay	assay	JJ	I-NP
were	were	VBD	0
detected	detected	VBN	0
using	using	VBG	0
a	a	DT	0
monoclonal	monoclonal	JJ	B-NP
antibody	antibody	NN	I-NP
to	to	TO	0
single-stranded	single-stranded	NNP	B-NP
DNA	DNA	NNP	I-NP
(	(	-LRB-	0
ssDNA	ssDNA	NNP	B-NP
)	)	-RRB-	0
(	(	-LRB-	0
Mab	Mab	NNP	B-NP
F7-26	F7-26	NNP	I-NP
)	)	-RRB-	0
according	according	VBG	0
to	to	TO	0
the	the	DT	0
method	method	NN	0
of	of	IN	0
Apostain	Apostain	NNP	B-NP
,	,	,	0
Inc	Inc	NNP	0
.	.	.	0
(	(	-LRB-	0
Miami	Miami	NNP	B-NP
,	,	,	0
FL	FL	NNP	B-NP
)	)	-RRB-	0
[	[	-LRB-	0
13	13	CD	0
]	]	-RRB-	0
.	.	.	0
monoclonal	monoclonal	JJ	B-NP
antibody	antibody	NN	I-NP
f7-26	f7-26	NN	I-NP
anti-ssdna	anti-ssdna	NN	I-NP
selective	selective	JJ	I-NP
binding	binding	NN	I-NP
to	to	TO	0
apoptotic	apoptotic	VB	0
nuclei	nuclei	NN	0
reflects	reflects	VBZ	0
dna	dna	NN	B-NP
decreased	decreased	VBN	I-NP
stability	stability	NN	I-NP
to	to	TO	0
thermal	thermal	JJ	B-NP
denaturation	denaturation	NN	I-NP
.	.	.	0
Four	Four	CD	0
positive	positive	JJ	0
and	and	CC	0
negative	negative	JJ	B-NP
control	control	NN	I-NP
were	were	VBD	0
conducted	conducted	VBN	0
.	.	.	0
negative	negative	JJ	B-NP
control	control	NN	I-NP
:	:	:	0
(	(	-LRB-	0
1	1	LS	0
)	)	-RRB-	0
Tissue	Tissue	NNP	0
sections	sections	NNS	0
were	were	VBD	0
heated	heated	VBN	0
and	and	CC	0
treated	treated	VBN	0
with	with	IN	0
S1	S1	CD	B-NP
nucleasa	nucleasa	NN	I-NP
(	(	-LRB-	0
Sigma	Sigma	NNP	B-NP
)	)	-RRB-	0
;	;	:	0
S1	S1	CD	B-NP
nuclease	nuclease	NN	I-NP
eliminates	eliminates	VBZ	0
staining	staining	VBN	0
of	of	IN	0
apoptotic	apoptotic	JJ	B-NP
cell	cell	NN	I-NP
,	,	,	0
thus	thus	RB	0
demonstrating	demonstrating	VBG	0
that	that	IN	0
Mab	Mab	NNP	B-NP
F7-26	F7-26	NNP	I-NP
binds	binds	VBD	0
specifically	specifically	RB	0
to	to	TO	0
single	single	JJ	B-NP
stranded	stranded	VBN	I-NP
dna	dna	NN	I-NP
(	(	-LRB-	0
2	2	LS	0
)	)	-RRB-	0
Sections	Sections	NNP	0
were	were	VBD	0
pretreated	pretreated	VBN	0
in	in	IN	0
containing	containing	VBG	B-NP
lysine-rich	lysine-rich	JJ	I-NP
histone	histone	NNS	I-NP
phosphate	phosphate	NN	I-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
(	(	-LRB-	0
Sigma	Sigma	NNP	B-NP
)	)	-RRB-	0
prior	prior	RB	0
to	to	TO	0
heating	heating	NN	0
and	and	CC	0
immunostaining	immunostaining	NN	B-NP
;	;	:	0
reconstitution	reconstitution	NN	B-NP
with	with	IN	0
histone	histone	JJ	0
restores	restores	JJ	0
DNA	DNA	NN	B-NP
stability	stability	NN	I-NP
in	in	IN	0
apoptotic	apoptotic	JJ	B-NP
nucleus	nucleus	NN	I-NP
,	,	,	0
thus	thus	RB	0
preventing	preventing	VBG	B-NP
DNA	DNA	NN	I-NP
denaturation	denaturation	NN	I-NP
and	and	CC	0
eliminating	eliminating	VBG	0
apoptotic	apoptotic	JJ	B-NP
cell	cell	NN	I-NP
mab	mab	NN	I-NP
staining	staining	NN	I-NP
.	.	.	0
positive	positive	JJ	B-NP
control	control	NN	I-NP
:	:	:	0
(	(	-LRB-	0
1	1	LS	0
)	)	-RRB-	0
Sections	Sections	NNP	0
were	were	VBD	0
heated	heated	VBN	0
in	in	IN	0
water	water	NN	0
and	and	CC	0
treated	treated	VBN	0
with	with	IN	0
Mab	Mab	NNP	B-NP
;	;	:	0
bright	bright	JJ	0
staining	staining	NN	0
of	of	IN	0
all	all	DT	0
non-apoptotic	non-apoptotic	JJ	B-NP
nucleus	nucleus	NN	I-NP
with	with	IN	0
low	low	JJ	0
apoptotic	apoptotic	JJ	B-NP
index	index	NN	I-NP
demonstrates	demonstrates	VBZ	0
that	that	IN	0
the	the	DT	0
procedure	procedure	NN	0
is	is	VBZ	0
adequate	adequate	JJ	0
to	to	TO	0
detect	detect	VB	0
single	single	JJ	B-NP
stranded	stranded	VBN	I-NP
dna	dna	NN	I-NP
(	(	-LRB-	0
2	2	LS	0
)	)	-RRB-	0
Sections	Sections	NNP	0
were	were	VBD	0
pretreated	pretreated	VBN	0
with	with	IN	0
proteinase	proteinase	JJ	B-NP
K	K	NN	I-NP
before	before	IN	0
heating	heating	NN	0
;	;	:	0
non-apoptotic	non-apoptotic	JJ	B-NP
nucleus	nucleus	NN	I-NP
intensive	intensive	JJ	I-NP
staining	staining	NN	I-NP
demonstrates	demonstrates	VBZ	0
that	that	IN	0
the	the	DT	0
procedure	procedure	NN	0
detects	detects	NNS	0
decreased	decreased	VBD	B-NP
DNA	DNA	NNP	I-NP
stability	stability	NN	I-NP
induced	induced	NN	I-NP
by	by	IN	0
the	the	DT	0
digestion	digestion	NN	0
of	of	IN	0
nuclear	nuclear	JJ	0
proteins	proteins	NNS	0
.	.	.	0
Mab	Mab	NNP	B-NP
F7-26	F7-26	NNP	I-NP
was	was	VBD	0
purchased	purchased	VBN	0
from	from	IN	0
Apostain	Apostain	NNP	B-NP
,	,	,	0
Inc	Inc	NNP	0
.	.	.	0
apoptotic	apoptotic	NN	B-NP
nucleus	nucleus	NN	I-NP
appear	appear	VBP	0
as	as	RB	0
dark	dark	JJ	0
brown	brown	NN	0
.	.	.	0
Since	Since	IN	0
the	the	DT	0
sections	sections	NNS	0
were	were	VBD	0
not	not	RB	0
counterstained	counterstained	VBN	0
with	with	IN	0
hematoxylin	hematoxylin	NN	B-NP
in	in	IN	0
this	this	DT	0
set	set	NN	0
of	of	IN	0
experiments	experiments	NNS	0
,	,	,	0
epithelial	epithelial	JJ	B-NP
cell	cell	NN	I-NP
cytoplasm	cytoplasm	NN	I-NP
appears	appears	VBZ	0
as	as	RB	0
light	light	JJ	0
brown	brown	NN	0
.	.	.	0
Only	Only	RB	0
apoptotic	apoptotic	JJ	0
(	(	-LRB-	0
variously	variously	RB	0
intense	intense	JJ	0
dark	dark	JJ	0
brown	brown	NN	0
)	)	-RRB-	0
nuclei	nuclei	NN	0
were	were	VBD	0
counted	counted	VBN	0
in	in	IN	0
control	control	NN	0
and	and	CC	0
sn50-treated	sn50-treated	NN	B-NP
section	section	NN	I-NP
.	.	.	0
apoptosi	apoptosi	NN	B-NP
was	was	VBD	0
evaluated	evaluated	VBN	0
in	in	IN	0
a	a	DT	0
minimum	minimum	NN	0
of	of	IN	0
4	4	CD	0
explant	explant	NN	B-NP
per	per	IN	0
experimental	experimental	JJ	B-NP
group	group	NN	I-NP
.	.	.	0
apoptotic	apoptotic	JJ	B-NP
nucleus	nucleus	NN	I-NP
quantitation	quantitation	NN	I-NP
was	was	VBD	0
conducted	conducted	VBN	0
as	as	RB	0
described	described	VBN	0
above	above	IN	0
for	for	IN	0
p53	p53	NN	B-NP
.	.	.	0
apoptosi	apoptosi	NN	B-NP
is	is	VBZ	0
presented	presented	VBN	0
as	as	IN	0
the	the	DT	0
ratio	ratio	NN	0
of	of	IN	0
apoptotic-positive	apoptotic-positive	NN	B-NP
epithelial	epithelial	NN	I-NP
cell	cell	NN	I-NP
nuclei/total	nuclei/total	NN	I-NP
epithelial	epithelial	NN	I-NP
cell	cell	NN	I-NP
nucleus	nucleus	NN	I-NP
.	.	.	0
mean	mean	JJ	B-NP
ratio	ratio	NN	I-NP
per	per	IN	0
section	section	NN	0
and	and	CC	0
mean	mean	VB	0
ratios	ratios	NNS	0
per	per	IN	0
group	group	NN	0
were	were	VBD	0
determined	determined	VBN	0
.	.	.	0
statistical	statistical	JJ	B-NP
comparison	comparison	NN	I-NP
were	were	VBD	0
made	made	VBN	0
between	between	IN	0
CONT	CONT	NNP	B-NP
and	and	CC	0
SN50-treated	SN50-treated	CD	B-NP
E15	E15	CD	I-NP
+	+	CD	0
2	2	CD	0
explant	explant	NN	B-NP
as	as	RB	0
described	described	VBD	0
below.	below.	CD	0
cdna	cdna	NN	B-NP
expression	expression	NN	I-NP
array	array	NN	I-NP
analysis	analysis	NN	I-NP
cdna	cdna	NN	I-NP
expression	expression	NN	I-NP
array	array	NN	I-NP
,	,	,	0
E15	E15	NNP	B-NP
SMG	SMG	NNP	I-NP
primordia	primordia	NN	I-NP
were	were	VBD	0
cultured	cultured	VBN	0
in	in	IN	0
the	the	DT	0
presence	presence	NN	0
or	or	CC	0
sn50	sn50	NN	B-NP
peptide	peptide	NN	I-NP
absence	absence	NN	I-NP
for	for	IN	0
2	2	CD	0
days	days	NNS	0
(	(	-LRB-	0
E15	E15	CD	B-NP
+	+	CD	0
2	2	CD	0
)	)	-RRB-	0
,	,	,	0
collected	collected	VBN	0
in	in	IN	0
cold	cold	JJ	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
containing	containing	VBG	0
0.02	0.02	CD	0
%	%	NN	0
DEPC	DEPC	NNP	B-NP
,	,	,	0
snap	snap	VBP	0
frozen	frozen	VBN	0
,	,	,	0
and	and	CC	0
stored	stored	VBD	0
at	at	IN	0
-70°C	-70°C	CD	0
.	.	.	0
Clontech	Clontech	NNP	B-NP
(	(	-LRB-	0
Clontech	Clontech	NNP	0
Laboratories	Laboratories	NNPS	0
,	,	,	0
Inc.	Inc.	NNP	0
,	,	,	0
Palo	Palo	NNP	B-NP
Alto	Alto	NNP	I-NP
,	,	,	0
cyproterone	cyproterone	NN	B-NP
acetate	acetate	NN	I-NP
)	)	-RRB-	0
Mouse	Mouse	NNP	0
1.2	1.2	CD	0
cdna	cdna	NN	B-NP
expression	expression	NN	I-NP
array	array	NN	I-NP
were	were	VBD	0
used	used	VBN	0
to	to	TO	0
analyze	analyze	VB	0
each	each	DT	0
sample	sample	NN	0
.	.	.	0
These	These	DT	0
arrays	arrays	NNS	0
include	include	VBP	0
1176	1176	CD	0
mouse	mouse	NN	B-NP
cdna	cdna	NN	I-NP
,	,	,	0
9	9	CD	0
housekeeping	housekeeping	JJ	0
control	control	NN	B-NP
cdna	cdna	NN	I-NP
,	,	,	0
and	and	CC	0
negative	negative	JJ	B-NP
control	control	NN	I-NP
immobilized	immobilized	VBN	0
on	on	IN	0
a	a	DT	0
nylon	nylon	JJ	B-NP
membrane	membrane	JJ	I-NP
www.clontech.com	www.clontech.com	NN	I-NP
.	.	.	0
Briefly	Briefly	RB	0
,	,	,	0
total	total	JJ	B-NP
RNA	RNA	NNP	I-NP
was	was	VBD	0
isolated	isolated	VBN	0
and	and	CC	0
cdna	cdna	NN	B-NP
probe	probe	NN	I-NP
were	were	VBD	0
synthesized	synthesized	VBN	0
using	using	VBG	0
the	the	DT	0
pure	pure	JJ	B-NP
total	total	JJ	I-NP
rna	rna	NN	I-NP
atlas	atlas	NN	I-NP
Labeling	Labeling	NNP	B-NP
System	System	NNP	I-NP
and	and	CC	0
32P	32P	NNP	0
.	.	.	0
The	The	DT	0
labeled	labeled	JJ	0
cdna	cdna	NN	B-NP
probe	probe	NN	I-NP
were	were	VBD	0
hybridized	hybridized	VBN	0
to	to	TO	0
the	the	DT	0
Atlas	Atlas	NNP	0
Array	Array	NNP	0
using	using	VBG	0
ExpressHyb	ExpressHyb	JJ	B-NP
Solution	Solution	NN	I-NP
.	.	.	0
hybridization	hybridization	NN	B-NP
signal	signal	JJ	I-NP
were	were	VBD	0
revealed	revealed	VBN	0
by	by	IN	0
phosphorimaging	phosphorimaging	NN	B-NP
and	and	CC	0
quantitated	quantitated	VBP	0
using	using	VBG	0
the	the	DT	0
Clontech	Clontech	NNP	B-NP
Atlas	Atlas	NNP	I-NP
Image	Image	NNP	I-NP
1.01	1.01	CD	0
software	software	NN	B-NP
package	package	NN	I-NP
,	,	,	0
which	which	WDT	0
allows	allows	VBZ	0
for	for	IN	0
unbiased	unbiased	JJ	0
transcript	transcript	JJ	B-NP
abundance	abundance	NN	I-NP
normalization	normalization	NN	I-NP
to	to	TO	0
overall	overall	JJ	0
signal	signal	NN	0
.	.	.	0
We	We	PRP	0
generated	generated	VBD	0
pseudocolored	pseudocolored	JJ	B-NP
image	image	NN	I-NP
indicating	indicating	VBG	0
up	up	RP	0
and	and	CC	0
down	down	JJ	0
gene	gene	NN	B-NP
regulation	regulation	NN	I-NP
.	.	.	0
The	The	DT	0
probe	probe	NN	B-NP
set	set	NN	I-NP
intensity	intensity	NN	I-NP
(	(	-LRB-	0
average	average	JJ	0
difference	difference	NN	0
)	)	-RRB-	0
is	is	VBZ	0
proportional	proportional	VBN	0
to	to	TO	0
the	the	DT	0
abundance	abundance	NN	B-NP
of	of	IN	0
the	the	DT	0
specific	specific	JJ	0
mRNA	mRNA	NN	B-NP
it	it	PRP	0
represents	represents	VBZ	0
and	and	CC	0
was	was	VBD	0
calculated	calculated	VBN	0
by	by	IN	0
comparing	comparing	VBG	0
control	control	NN	B-NP
oligonucleotide	oligonucleotide	NN	I-NP
hybridization	hybridization	JJ	I-NP
signal	signal	NN	I-NP
to	to	TO	0
that	that	DT	0
of	of	IN	0
the	the	DT	0
treated	treated	NN	0
.	.	.	0
Total	Total	JJ	B-NP
signal	signal	NN	I-NP
intensity	intensity	NN	I-NP
of	of	IN	0
different	different	JJ	0
probes	probes	NNS	0
was	was	VBD	0
scaled	scaled	VBN	0
to	to	TO	0
the	the	DT	0
same	same	JJ	0
value	value	NN	0
before	before	IN	0
comparison	comparison	NN	0
.	.	.	0
Fold	Fold	JJ	0
changes	changes	NNS	0
were	were	VBD	0
calculated	calculated	VBN	0
by	by	IN	0
AtlasImage	AtlasImage	JJ	0
1.0	1.0	CD	0
software	software	NN	0
by	by	IN	0
pair-wise	pair-wise	JJ	B-NP
comparison	comparison	NN	I-NP
of	of	IN	0
corresponding	corresponding	JJ	0
probe	probe	NN	B-NP
pair	pair	NN	I-NP
from	from	IN	0
experimental	experimental	JJ	0
and	and	CC	0
control	control	NN	0
.	.	.	0
Three	Three	CD	0
independent	independent	JJ	0
experiments	experiments	NNS	0
were	were	VBD	0
conducted	conducted	VBN	0
per	per	IN	0
experimental	experimental	JJ	B-NP
group	group	NN	I-NP
and	and	CC	0
the	the	DT	0
composite	composite	JJ	0
array	array	NN	0
determined	determined	VBN	0
.	.	.	0
relevant	relevant	JJ	B-NP
gene	gene	NN	I-NP
with	with	IN	0
altered	altered	JJ	0
expression	expression	NN	0
were	were	VBD	0
then	then	RB	0
assigned	assigned	VBN	0
to	to	TO	0
functional	functional	VB	B-NP
group	group	NN	I-NP
.	.	.	0
Specifically	Specifically	RB	0
,	,	,	0
we	we	PRP	0
assigned	assigned	VBD	0
those	those	DT	0
genes	genes	NNS	0
related	related	VBN	0
to	to	TO	0
the	the	DT	0
Connections	Connections	NNP	B-NP
Map	Map	NNP	I-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
1	1	CD	0
)	)	-RRB-	0
that	that	WDT	0
have	have	VBP	0
a	a	DT	0
1.5	1.5	CD	0
or	or	CC	0
greater	greater	JJR	0
fold-change	fold-change	JJ	B-NP
to	to	TO	0
functional	functional	VB	B-NP
group	group	NN	I-NP
(	(	-LRB-	0
i.e.	i.e.	FW	0
,	,	,	0
cell	cell	NN	B-NP
cycle	cycle	NN	I-NP
,	,	,	0
apoptosi	apoptosi	NN	B-NP
,	,	,	0
signal	signal	NN	B-NP
transduction	transduction	NN	I-NP
,	,	,	0
etc.	etc.	FW	0
)	)	-RRB-	0
which	which	WDT	0
have	have	VBP	0
biological	biological	JJ	B-NP
significance.	significance.	CD	I-NP
2-D	2-D	CD	B-NP
western	western	JJ	0
array	array	NN	0
screening	screening	VBG	0
The	The	DT	0
expression	expression	NN	0
of	of	IN	0
signaling	signaling	VBG	B-NP
protein	protein	NN	I-NP
was	was	VBD	0
analyzed	analyzed	VBN	0
by	by	IN	0
Powerblot	Powerblot	NNP	B-NP
Western	Western	NNP	I-NP
Array	Array	NNP	I-NP
Screening	Screening	NNP	0
(	(	-LRB-	0
BD	BD	NNP	0
Transduction	Transduction	NNP	0
Laboratories	Laboratories	NNPS	0
,	,	,	0
Lexington	Lexington	NNP	B-NP
,	,	,	0
KY	KY	NNP	B-NP
)	)	-RRB-	0
.	.	.	0
This	This	DT	0
2-D	2-D	NNP	B-NP
Western	Western	NNP	I-NP
Blot	Blot	NNP	I-NP
Array	Array	NNP	I-NP
methodology	methodology	VBD	I-NP
simultaneously	simultaneously	RB	0
examines	examines	VBZ	0
relative	relative	JJ	B-NP
change	change	NN	I-NP
in	in	IN	0
protein	protein	NN	B-NP
expression	expression	NN	I-NP
in	in	IN	0
~600	~600	CD	0
proteins	proteins	NNS	0
in	in	IN	0
a	a	DT	0
given	given	VBN	0
sample	sample	NN	0
.	.	.	0
Using	Using	VBG	0
highly	highly	RB	0
specific	specific	JJ	0
monoclonal	monoclonal	JJ	B-NP
antibody	antibody	NN	I-NP
in	in	IN	0
antibody	antibody	NN	B-NP
combination	combination	NN	I-NP
carefully	carefully	RB	0
formulated	formulated	VBN	0
by	by	IN	0
BD	BD	NNP	0
Transduction	Transduction	NNP	0
Laboratories	Laboratories	NNPS	0
,	,	,	0
this	this	DT	0
multiprotein	multiprotein	JJ	B-NP
assay	assay	JJ	I-NP
detects	detects	JJ	0
proteins	proteins	NNS	0
to	to	TO	0
the	the	DT	0
nanogram	nanogram	JJ	B-NP
level	level	JJ	I-NP
and	and	CC	0
can	can	MD	0
distinguish	distinguish	VB	0
closely	closely	RB	0
related	related	VBN	0
members	members	NNS	0
of	of	IN	0
many	many	JJ	0
important	important	JJ	0
signaling	signaling	JJ	0
families	families	NNS	0
.	.	.	0
E15+2	E15+2	NNP	B-NP
CONT	CONT	NNP	B-NP
and	and	CC	0
sn50-treated	sn50-treated	NN	B-NP
explant	explant	NN	I-NP
were	were	VBD	0
collected	collected	VBN	0
and	and	CC	0
processed	processed	VBN	0
according	according	VBG	0
to	to	TO	0
the	the	DT	0
protocol	protocol	NN	0
of	of	IN	0
BD	BD	NNP	0
Transduction	Transduction	NNP	0
Laboratories	Laboratories	NNPS	0
.	.	.	0
Each	Each	DT	0
sample	sample	NN	0
(	(	-LRB-	0
CONT	CONT	NNP	B-NP
and	and	CC	0
SN50-treated	SN50-treated	CD	B-NP
)	)	-RRB-	0
was	was	VBD	0
analyzed	analyzed	VBN	0
on	on	IN	0
4	4	CD	0
separate	separate	JJ	0
2-d	2-d	NN	B-NP
gel	gel	NN	I-NP
which	which	WDT	0
were	were	VBD	0
then	then	RB	0
transferred	transferred	VBN	0
onto	onto	IN	0
4	4	CD	0
blots	blots	NNS	0
.	.	.	0
Each	Each	DT	0
blot	blot	NN	0
was	was	VBD	0
then	then	RB	0
incubated	incubated	VBN	0
with	with	IN	0
a	a	DT	0
different	different	JJ	0
mixture	mixture	NN	0
of	of	IN	0
~150	~150	CD	0
monoclonal	monoclonal	CD	B-NP
antibody	antibody	NN	I-NP
and	and	CC	0
proteins	proteins	NNS	0
were	were	VBD	0
detected	detected	VBN	0
by	by	IN	0
chemiluminescenca	chemiluminescenca	NN	B-NP
;	;	:	0
~600	~600	CD	0
(	(	-LRB-	0
150	150	CD	0
antibody	antibody	NN	B-NP
×	×	CD	0
4	4	CD	0
blots	blots	CD	0
)	)	-RRB-	0
proteins	proteins	NNS	0
were	were	VBD	0
evaluated	evaluated	VBN	0
in	in	IN	0
a	a	DT	0
given	given	VBN	0
sample	sample	NN	0
.	.	.	0
For	For	IN	0
this	this	DT	0
set	set	NN	0
of	of	IN	0
experiments	experiments	NNS	0
,	,	,	0
two	two	CD	0
independent	independent	JJ	0
samples	samples	NNS	0
were	were	VBD	0
analyzed	analyzed	VBN	0
The	The	DT	0
relative	relative	JJ	B-NP
level	level	NN	I-NP
of	of	IN	0
proteins	proteins	NNS	0
were	were	VBD	0
determined	determined	VBN	0
by	by	IN	0
phosphor	phosphor	JJ	B-NP
imaging	imaging	NN	I-NP
and	and	CC	0
normalized	normalized	JJ	0
to	to	TO	0
overall	overall	JJ	0
signal	signal	NN	0
.	.	.	0
We	We	PRP	0
then	then	RB	0
assigned	assigned	VBN	0
those	those	DT	0
Connections	Connections	NNP	0
map	map	NN	B-NP
protein	protein	NN	I-NP
with	with	IN	0
a	a	DT	0
1.5	1.5	CD	0
or	or	CC	0
greater	greater	JJR	0
fold-change	fold-change	JJ	B-NP
to	to	TO	0
functional	functional	VB	B-NP
group	group	NN	I-NP
as	as	RB	0
described	described	VBD	0
above.	above.	CD	0
1-D	1-D	CD	B-NP
western	western	JJ	0
blot	blot	JJ	0
analysis	analysis	NN	0
To	To	TO	0
determine	determine	VB	0
which	which	WDT	0
key	key	JJ	B-NP
pathway	pathway	NN	I-NP
were	were	VBD	0
activated	activated	VBN	0
,	,	,	0
Western	Western	JJ	0
blot	blot	JJ	0
analyses	analyses	NNS	0
of	of	IN	0
phosphorylated	phosphorylated	NN	0
or	or	CC	0
cleaved	cleaved	JJ	0
proteins	proteins	NNS	0
in	in	IN	0
E15+2	E15+2	NNP	B-NP
CONT	CONT	NNP	B-NP
and	and	CC	0
sn50-treated	sn50-treated	NN	B-NP
explant	explant	NN	I-NP
were	were	VBD	0
conducted	conducted	VBN	0
as	as	IN	0
previously	previously	RB	0
described	described	VBN	0
[	[	-LRB-	0
5	5	LS	0
]	]	-RRB-	0
.	.	.	0
For	For	IN	0
this	this	DT	0
set	set	NN	0
of	of	IN	0
experiments	experiments	NNS	0
,	,	,	0
we	we	PRP	0
first	first	RB	0
determined	determined	VBN	0
the	the	DT	0
specificity	specificity	NN	0
for	for	IN	0
each	each	DT	0
of	of	IN	0
the	the	DT	0
following	following	JJ	0
antibody	antibody	NN	B-NP
purchased	purchased	VBN	0
from	from	IN	0
Cell	Cell	NNP	0
Signaling	Signaling	NNP	B-NP
Technology	Technology	NNP	I-NP
(	(	-LRB-	0
Beverly	Beverly	NNP	0
,	,	,	0
MA	MA	NNP	0
)	)	-RRB-	0
using	using	VBG	0
E15	E15	NNP	B-NP
and	and	CC	0
e17	e17	NN	B-NP
smg	smg	NN	I-NP
homogenate	homogenate	NN	I-NP
:	:	:	0
anti-phosphorylated	anti-phosphorylated	JJ	B-NP
Erk1	Erk1	CD	I-NP
/	/	CD	0
2	2	CD	0
[	[	-LRB-	0
phospho-p44	phospho-p44	CD	B-NP
/	/	CD	0
42	42	CD	0
MAP	MAP	NN	B-NP
kinasa	kinasa	NN	I-NP
(	(	-LRB-	0
Thr202	Thr202	CD	B-NP
/	/	CD	0
Tyr204	Tyr204	CD	B-NP
)	)	-RRB-	0
]	]	-RRB-	0
antibody	antibody	NN	B-NP
,	,	,	0
anti-phosphorylated	anti-phosphorylated	NNP	B-NP
c-Raf	c-Raf	NNP	I-NP
(	(	-LRB-	I-NP
Ser259	Ser259	NNP	I-NP
)	)	-RRB-	I-NP
antibody	antibody	NN	I-NP
,	,	,	0
anti-cleaved	anti-cleaved	NNP	B-NP
Caspase	Caspase	NNP	I-NP
3	3	CD	0
(	(	-LRB-	0
D	D	NNP	0
175	175	CD	0
)	)	-RRB-	0
antibody	antibody	NN	B-NP
,	,	,	0
and	and	CC	0
anti-cleaved	anti-cleaved	NNP	B-NP
PARP	PARP	NNP	I-NP
(	(	-LRB-	0
D214	D214	NNP	B-NP
)	)	-RRB-	0
antibody	antibody	NN	B-NP
.	.	.	0
Each	Each	DT	0
antibody	antibody	NN	B-NP
had	had	VBD	0
previously	previously	RB	0
been	been	VBN	0
shown	shown	VBN	0
to	to	TO	0
be	be	VB	0
specific	specific	JJ	0
for	for	IN	0
the	the	DT	0
activated	activated	NN	0
(	(	-LRB-	0
phosphorylated	phosphorylated	FW	0
/	/	FW	0
cleaved	cleaved	FW	0
)	)	-RRB-	0
protein	protein	NN	B-NP
and	and	CC	0
not	not	RB	0
to	to	TO	0
cross	cross	VB	0
react	react	VBN	0
with	with	IN	0
inactive	inactive	JJ	B-NP
protein	protein	NN	I-NP
.	.	.	0
Once	Once	RB	0
optimal	optimal	JJ	B-NP
experimental	experimental	JJ	I-NP
condition	condition	NN	I-NP
were	were	VBD	0
established	established	VBN	0
for	for	IN	0
each	each	DT	0
antibody	antibody	NN	B-NP
,	,	,	0
we	we	PRP	0
then	then	RB	0
incubated	incubated	JJ	0
blots	blots	NN	0
of	of	IN	0
E15	E15	NNP	B-NP
and	and	CC	0
e17	e17	NN	B-NP
smg	smg	NN	I-NP
in	in	IN	0
a	a	DT	0
mixture	mixture	NN	0
of	of	IN	0
these	these	DT	0
4	4	CD	0
antibody	antibody	NN	B-NP
and	and	CC	0
determined	determined	VBN	0
that	that	IN	0
we	we	PRP	0
could	could	MD	0
identify	identify	VB	0
all	all	DT	0
proteins	proteins	NNS	0
in	in	IN	0
a	a	DT	0
single	single	JJ	0
sample	sample	NN	0
by	by	IN	0
M	M	NNP	0
r	r	NN	0
.	.	.	0
This	This	DT	0
methodology	methodology	NN	0
using	using	VBG	0
a	a	DT	0
mixture	mixture	NN	0
of	of	IN	0
antibody	antibody	NN	B-NP
has	has	VBZ	0
been	been	VBN	0
successfully	successfully	RB	0
used	used	VBN	0
by	by	IN	0
Cell	Cell	NNP	0
Signaling	Signaling	NNP	B-NP
Technology	Technology	NNP	I-NP
and	and	CC	0
2-d	2-d	NN	B-NP
bd	bd	NN	I-NP
signal	signal	JJ	I-NP
transduction	transduction	NN	I-NP
and	and	CC	0
1-d	1-d	NN	B-NP
western	western	JJ	I-NP
blot	blot	NN	I-NP
analysis	analysis	NN	I-NP
.	.	.	0
Controls	Controls	NNS	0
consisted	consisted	VBD	0
of	of	IN	0
blots	blots	JJ	0
incubated	incubated	NN	0
in	in	IN	0
preimmune	preimmune	JJ	B-NP
rabbit	rabbit	NN	I-NP
serum	serum	NN	I-NP
or	or	CC	0
in	in	IN	0
the	the	DT	0
primary	primary	JJ	B-NP
antibody	antibody	NN	I-NP
absence	absence	NN	I-NP
;	;	:	0
controls	controls	NNS	0
were	were	VBD	0
routinely	routinely	RB	0
negative	negative	JJ	0
.	.	.	0
In	In	IN	0
each	each	DT	0
sample	sample	NN	0
,	,	,	0
each	each	DT	0
activated	activated	JJ	0
protein	protein	NN	B-NP
was	was	VBD	0
identified	identified	VBN	0
by	by	IN	0
M	M	NNP	0
r	r	NN	0
and	and	CC	0
the	the	DT	0
relative	relative	JJ	B-NP
level	level	NN	I-NP
of	of	IN	0
activated	activated	JJ	0
proteins	proteins	NNS	0
in	in	IN	0
CONT	CONT	NNP	B-NP
and	and	CC	0
sn50-treated	sn50-treated	NN	B-NP
explant	explant	NN	I-NP
was	was	VBD	0
determined	determined	VBN	0
by	by	IN	0
densitometry	densitometry	NN	B-NP
.	.	.	0
The	The	DT	0
sn50	sn50	NN	B-NP
result	result	NN	I-NP
are	are	VBP	0
presented	presented	VBN	0
as	as	IN	0
fold	fold	JJ	0
change	change	NN	0
relative	relative	JJ	0
to	to	TO	0
CONT	CONT	NNP	B-NP
protein	protein	NN	I-NP
.	.	.	0
Two	Two	CD	0
independent	independent	JJ	0
samples	samples	NNS	0
per	per	IN	0
group	group	NN	0
was	was	VBD	0
analyzed	analyzed	VBN	0
.	.	.	0
statistical	statistical	JJ	B-NP
comparison	comparison	NN	I-NP
were	were	VBD	0
made	made	VBN	0
between	between	IN	0
CONT	CONT	NNP	B-NP
and	and	CC	0
SN50-treated	SN50-treated	CD	B-NP
E15	E15	CD	I-NP
+	+	CD	0
2	2	CD	0
explant	explant	NN	B-NP
as	as	RB	0
described	described	VBN	0
below	below	RB	0
.	.	.	0
Probabilistic	Probabilistic	JJ	B-NP
neural	neural	JJ	I-NP
network	network	NN	I-NP
analysis	analysis	NN	I-NP
We	We	PRP	0
used	used	VBD	0
pnn	pnn	NN	B-NP
analysis	analysis	NN	I-NP
to	to	TO	0
determine	determine	VB	0
which	which	WDT	0
Connection	Connection	NNP	B-NP
Map	Map	NNP	I-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
1	1	CD	0
)	)	-RRB-	0
transcripts	transcripts	NNS	0
or	or	CC	0
proteins	proteins	NNS	0
with	with	IN	0
altered	altered	JJ	0
expression	expression	NN	0
best	best	RBS	0
discriminate	discriminate	JJ	0
CONT	CONT	NN	B-NP
from	from	IN	0
sn50-treated	sn50-treated	NN	B-NP
explant	explant	NN	I-NP
with	with	IN	0
100	100	CD	0
%	%	NN	0
sensitivity	sensitivity	NN	0
and	and	CC	0
specificity	specificity	NNS	0
[	[	-LRB-	0
69	69	CD	0
]	]	-RRB-	0
.	.	.	0
pnn	pnn	NN	B-NP
analysis	analysis	NN	I-NP
identify	identify	VBP	0
the	the	DT	0
relative	relative	JJ	B-NP
importance	importance	NN	I-NP
(	(	-LRB-	0
0-1	0-1	NNP	0
,	,	,	0
with	with	IN	0
0	0	CD	0
being	being	VBG	0
of	of	IN	0
no	no	DT	0
relative	relative	JJ	B-NP
importance	importance	NN	I-NP
and	and	CC	0
1	1	CD	0
being	being	VBG	0
relatively	relatively	RB	0
most	most	RBS	0
important	important	JJ	0
)	)	-RRB-	0
of	of	IN	0
gene	gene	NN	0
and	and	CC	0
protein	protein	NN	B-NP
expression	expression	NN	I-NP
change	change	NN	I-NP
in	in	IN	0
defining	defining	VBG	0
the	the	DT	0
SN50	SN50	JJ	B-NP
phenotype	phenotype	NN	I-NP
.	.	.	0
It	It	PRP	0
is	is	VBZ	0
the	the	DT	0
change	change	NN	0
in	in	IN	0
expression	expression	NN	0
,	,	,	0
not	not	RB	0
the	the	DT	0
direction	direction	NN	0
of	of	IN	0
change	change	NN	0
,	,	,	0
that	that	WDT	0
is	is	VBZ	0
important	important	JJ	0
in	in	IN	0
defining	defining	VBG	0
the	the	DT	0
phenotype	phenotype	NN	B-NP
.	.	.	0
The	The	DT	0
algorithm	algorithm	NN	B-NP
we	we	PRP	0
used	used	VBD	0
(	(	-LRB-	0
Ward	Ward	NNP	0
Systems	Systems	NNPS	0
Group	Group	NNP	0
,	,	,	0
Frederick	Frederick	NNP	0
,	,	,	0
MD	MD	NNP	0
)	)	-RRB-	0
is	is	VBZ	0
based	based	VBN	0
upon	upon	IN	0
the	the	DT	0
work	work	NN	0
of	of	IN	0
Specht	Specht	NNP	0
and	and	CC	0
colleagues	colleagues	NNS	0
[	[	-LRB-	0
69	69	CD	0
70	70	CD	0
71	71	CD	0
72	72	CD	0
]	]	-RRB-	0
.	.	.	0
Utilizing	Utilizing	JJ	B-NP
proprietary	proprietary	JJ	I-NP
software	software	NN	I-NP
designed	designed	VBN	0
by	by	IN	0
Ward	Ward	NNP	0
Systems	Systems	NNPS	0
Group	Group	NNP	0
(	(	-LRB-	0
Frederick	Frederick	NNP	0
,	,	,	0
MD	MD	NNP	0
)	)	-RRB-	0
,	,	,	0
we	we	PRP	0
made	made	VBD	0
comparisons	comparisons	NNS	0
among	among	IN	0
Connections	Connections	NNP	0
map	map	NN	B-NP
transcript	transcript	NN	I-NP
or	or	CC	0
proteins	proteins	NNS	0
with	with	IN	0
altered	altered	JJ	0
expression	expression	NN	0
in	in	IN	0
a	a	DT	0
given	given	VBN	0
group	group	NN	0
.	.	.	0
Statistical	Statistical	JJ	B-NP
analysis	analysis	NN	I-NP
Means	Means	VBZ	0
differences	differences	NNS	0
were	were	VBD	0
analyzed	analyzed	VBN	0
by	by	IN	0
t-test	t-test	JJ	B-NP
in	in	IN	0
the	the	DT	0
usual	usual	JJ	0
manner	manner	NN	0
[	[	-LRB-	0
73	73	CD	0
]	]	-RRB-	0
.	.	.	0
To	To	TO	0
meet	meet	VB	0
the	the	DT	0
assumptions	assumptions	NNS	0
of	of	IN	0
this	this	DT	0
analysis	analysis	NN	0
,	,	,	0
namely	namely	RB	0
normality	normality	JJ	0
and	and	CC	0
homoscedasticity	homoscedasticity	NN	B-NP
(	(	-LRB-	0
homogeneity	homogeneity	NN	0
of	of	IN	0
variances	variances	CD	0
)	)	-RRB-	0
,	,	,	0
counts	counts	NNS	0
,	,	,	0
ratios	ratios	NNS	0
,	,	,	0
and	and	CC	0
percentages	percentages	NNS	0
were	were	VBD	0
log	log	JJ	0
or	or	CC	0
arcsin	arcsin	JJ	0
transformed	transformed	NNS	0
[	[	-LRB-	0
74	74	CD	0
]	]	-RRB-	0
.	.	.	0
This	This	DT	0
allows	allows	VBZ	0
for	for	IN	0
parametric	parametric	JJ	B-NP
statistical	statistical	JJ	I-NP
testing	testing	NN	I-NP
.	.	.	0
